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Blood count is one of the most common medical laboratory tests performed today.  
It provides information on patient’s oxygen carrying capacity, immune system 
functionality, and the overall hemapoiesis process for disease diagnosis and drug 
side-effect monitoring.  Traditionally blood count is performed either manually or by 
conventional automated blood analyzers.  With the advance of microfabrication, on-chip 
blood count has become a target for miniaturization aiming at providing cost-effective, 
functional, capable point-of-care devices and systems that use less than 100 nL of blood 
sample and generate measurement results within minutes.  The focus of this thesis is on 
investigation of erythrocyte/leukocyte counting and leukocyte differential, which are the 
two key components in blood count, in microdevices. 
Due to the large number ratio of erythrocytes to leukocytes and their property 
overlap, conventional automated blood analyzers accomplish blood count in several 
viii 
different channels by measuring different parameters.  Similarly, in microdevices, it is 
desirable that erythrocytes and leukocytes can be separated before further analysis.  Two 
types of hydrodynamic separation devices were investigated to continuously separate 
erythrocytes and leukocytes based on size.  The principle of the device exploits the 
laminar flow in microdevices and design of streamlines which particles follow.  
Pillar-shaped devices with single geometrical design demonstrate a binary separation 
profile.  With proper design, separation efficiency over 90% can be achieved.  
Channel-shaped devices, an improved design, can achieve similar separation efficiency 
with the added benefits of a smaller footprint, fewer requirements on flow control, and 
easier integration with downstream components. 
Erythrocyte and leukocyte count is accomplished with electrical impedance 
sensing, which is one of the most accurate ways to measure particle volume.  The 
well-known problem of small double-layer capacitance inherent to micro impedance 
sensors is solved by two methods: platinum black electroplating on the electrode surface 
and inductor-induced resonance sensing.  In the first method, platinum black is 
electroplated in situ on the electrode surfaces, which increases the effective surface area 
by two orders of magnitude and thus increases the double-layer capacitance significantly.  
The other innovative way, inductor-induced resonance sensing, nullifies the capacitive 
components in the system at the resonance frequency by connecting a parallel inductor to 
the system.  In this way the sensitivity can be greatly improved and the optimal sensing 
frequency can be chosen from the inductance value.  For both methods, polystyrene 
ix 
beads of different diameters were used for validation, while diluted blood samples and 
leukocyte-rich plasma were used to successfully demonstrate the feasibility. 
Two-part leukocyte differential is demonstrated in microflow cytometers with 
fluorescence sensing.  Unlike methods used in conventional blood analyzers, undiluted 
blood samples are stained with nucleic acid stain acridine orange.  Lymphocytes and 
granulocytes emit fluorescent light at different peak frequency after interaction with the 
dye due to the difference in cellular composition.  Using the undiluted sample greatly 
minimizes sample preparation procedure, and reduces the overall measurement time, the 
reagent, and the waste volume.  These benefits make it a practical method for 
implementation in microdevices.  A throughput of one thousand leukocytes per second 
was demonstrated, which means the leukocyte differential could be accomplished in a 
couple of seconds. 
x 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Complete blood count 
1.1.1 Complete blood count and its clinical significance 
On average, an adult human male weighing 70 kg contains a blood volume of 
approximately 5 liters [1, 2]. Remarkably, this entire volume of blood circulates the body 
once every minute and serves a wide variety of important functions. [3]. Some of these 
functions include: delivering oxygen and nutrients to every cell of the body, transporting 
intermediate metabolites and wastes from and toward various tissues, and transporting 
cells of the immune system throughout the body to perform specific immuno-surveillance 
functions. Thus, a great deal of information about a given person’s body can be inferred 
by examination of their blood. 
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As a result, there have been many laboratory tests devised to assist in medical 
diagnoses; the most ubiquitous of these tests is the complete blood count (CBC). The 
CBC test determines, as a proportion or absolute number, the quantity of two or more of 
the following cells present in whole blood:  erythrocytes (red blood cell, RBC), 
leukocytes (white blood cell, WBC), platelets (thrombocytes), and hemoglobin. In 
addition, the CBC determines the hematocrit (volume ratio of erythrocytes in whole 
blood), as well as performing what is known as a leukocyte differential. There are many 
different types of leukocytes. A leukocyte differential further determines, as a ratio or 
absolute number, the quantity of various types of leukocytes. Leukocyte differential tests 
come in several types differing in number and types of cells compared. Examples of these 
tests include; 2-part (lymphocytes versus granulocytes), 3-part (lymphocytes, monocytes, 
and granulocytes), and 5-part (lymphocytes, monocytes, neutrophils, eosinophils, and 
basophils) comparisons.  Modern automated blood analyzers can provide 5-part absolute 
leukocyte differentials.  Depending on the instrument manufacturer, these modern 
instruments can measure over 20 parameters, including reticulocyte count.  Tables 1-1 
and 1-2 list the most common parameters for CBC tests as well as their recommended 
normal range [4, 5]. 
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Table 1-1 Complete blood count and the normal ranges 
WBC  4,500 to 11,000 /μL 
Differential white cell count  See Table 2 
RBC  4.0 to 6.2 million /μL 
Hematocrit  
 Women  35% to 47% 
 Men 8 to 64 yr 39% to 50% 
 Men 65 to 74 yr 37% to 51% 
Hemoglobin concentration  
 Women  12 to 16 g/dL 
 Men  14 to 18 g/dL 
RBC indices  
 Mean corpuscular volume (MCV) 82 to 93 μm3 
 Mean corpuscular Hgb (MCH) 26 to 34 pg 
 Mean corpuscular Hgb concentration  (MCHC) 31% to 38% 
Platelet count  150,000 to 400,000 /μL 
 
Table 1-2 Leukocyte differential and the normal ranges 
Cell Type  Absolute (/μL) Differential (%) 
Total WBC  4,500−11,000 100 
Granulocytes   
 Neutrophils  3,000−7,000 60−70 
  Segmented  2,800−5,600 54−68 
  Bands  150−600 3−5 
 Eosinophils  50−400 1−5 
 Basophils  25−100 0−0.75 
Nongranulocyte   
 Monocytes  100−800 3−7 
 Lymphocytes (Immunocytes)  1,000−4,000 25−33 
  T cells  800−3,200 80* 
  B cells  100−600 10−15* 
  Natural killer  50−400 5−10* 
*Percent of total lymphocyte count 
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It turns out that the wealth of data provided by the CBC is extremely useful in 
diagnosing the presence, severity, and/or type of the following: anemia, certain cancers, 
infection, acute hemorrhagic states, various allergies, immunodeficiency, and certain 
drugs that cause blood dyscrasias [4]. The following sections go into more detail about 
how CBC data, specifically from leukocyte differential tests, is used to assist in the 
diagnoses of previously mentioned conditions. 
Abnormal leukocyte (WBC) differential results are indicatives of disease 
processes and toxic challenges to the body [4−6]. Leukocyte abnormalities can be 
broadly classified into five categories: neutrophilia, eosinophilia, basophilia, monocytosis, 
and lymphocytosis. 
Neutrophilia is an increase in the total neutrophil count (both segmented and band 
form).  Neutrophilia may also be referred to as granulocytosis because neutrophils 
account for greater than 96% of all granulocytes.  It is the most common cause of 
elevated WBC count and is most commonly caused by an acute bacterial infection and 
less commonly caused by a Myeloproliferative disorder.  An elevation in segmented 
neutrophils is referred to as a “shift to the right” and is often observed during tissue 
breakdown from injuries such as burns, arthritis, myocardial infarction, hemorrhage, or 
electric shock.  The correlation between a shift to the right and tissue breakdown is 
intuitively satisfying because neutrophils are called in to clean up the damaged or dead 
cells.  An elevation in the band form of neutrophils is referred to as a, “shift to the left,” 
which means that an increased number of immature neutrophils have been released from 
the bone marrow and are circulating in the blood.  This condition occurs in response to 
overwhelming infection when mature neutrophil reserves have been depleted.  In general, 
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a shift to the right can be considered a result of tissue damage or necrosis, whereas a shift 
to the left can be considered a result of an overwhelming infection.   
Eosinophilia is an increase in the eosinophil count.  Eosinophilia has been found 
to increase in the presence of parasitic infections, bronchoallergic reactions (i.e., asthma), 
allergic rhinitis, hay fever, and skin rashes.   
Basophila is an increase in the basophil count.  It is also the most uncommon 
cause of an elevated WBC count.  Basophil increases have been known to occur in some 
hypersensitivity reactions, excessive radiation exposure, myeloproliferative disorders, 
(including polycythemia vera), myelofibrosis with myeloid metaplasia, and chronic 
granulocytic leukemia (CGL).   
Monocytosis, as one can probably infer by now, is an increase in the monocyte 
count. Monocytosis occurs late during either the acute phase of infection or with chronic 
infections such as tuberculosis and subacute bacterial endocarditis (SBE).   
Lymphocytosis occurs in acute viral infections such as mononucleosis, 
cytomegalovirus, measles, mumps, and rubella.  Elevated lymphocyte counts will also be 
noted in patients during with a history of chronic infections and may be noted early in 
patients carrying the human immunodeficiency virus (HIV) disease.  Severely elevated 
levels are seen in chronic lymphocytic leukemia (CLL). 
1.1.2 Technology development for complete blood count 
Like many other fields of scientific inquiry, our knowledge of blood has evolved 
in parallel and in proportion with the technology developed for blood analysis [7].  
Although blood has been considered the essence of life for centuries, the cellular 
composition of blood was not recognized until the invention of the microscope by 
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Leeuwenhoek in the 17th century.  In 1852, Karl Vierordt published the first quantitative 
results of blood cell analysis based on a tedious and lengthy procedure [8].  Later in the 
19th century, the improvement of tissue-staining techniques enabled the first manual 
blood count by means of a combination of hemacytomers and blood smear.  Eosin was 
the first of these tissue-staining dyes discovered in 1856, followed by hematoxylin 
(discovered in 1865), and later by the metachromatic Romanowsky dyes. Amazingly, 
modern manual blood count methods are not significantly different from those used over 
a century ago and those are still the traditional reference method used for calibration of 
automated blood analyzers.  Belonging to the Romanowsky dye family, Wright or 
Wright-Giemsa staining is the dye most commonly used for blood smear in North 
America, while May-Grunwald-Giemsa type staining is more popular in Europe and 
elsewhere [6]. 
The technological evolution for automated blood count began in mid-1950s. 
When researchers embarked on the development of automated blood analysis, the 
ultimate goal of their efforts was to build a device which could provide fast, reliable, and 
automated 5-part leukocyte differential analysis.  Thus far, two different 
approaches/platforms have been explored.  One approach is to build a system based on 
microscope image analysis.  The other approach is to adapt flow-cytometer-based sensing.  
Attempts to automate WBC differential counting by image analysis using computer-
based algorithms [9, 10] are in general not very successful in real clinic patients.  These 
systems are slower and require large amounts of operator interaction [6]. Microscope-
based image analysis is primarily constrained by available computing power and 
algorithm development. However, given the rapid pace  of technological advancement in 
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the fields of computing power and algorithm design this situation might change and 
present constraints on this method may be alleviated [11]. The flow cytometer platform 
for blood count is achieved by letting blood cells flow through a restricted sensing zone 
one by one.  Normally, sheath flow and small aperture or capillary tubes are used to 
achieve this [12].  Classification and enumeration is achieved by combining sensor 
signals of, for example, DC/AC impedance, forward and side light scattering and/or 
fluorescence [13].  The first generation of flow cytometer based systems achieved 3-part 
leukocyte differential separations [14−16].  Although these instruments have their own 
flagging systems and review criteria, such rule-based systems were surprisingly good at 
predicting abnormalities in patient specimens requiring manual review or enumeration [6].  
The next development came with the introduction of enzyme cytochemical treatments for 
leukocytes, which enabled 5-part leukocyte differential.  The first automated blood 
analyzer with 5-part differential capability was introduced in the mid 1970s [17, 18].  
Since then, bivariate scatterplots have replaced single parameter histograms for data 
representation.  Also, adaptable cluster analysis algorithms have replaced earlier criteria 
of fixed discriminators.  Modern automated blood analyzers rely more on multi-
parameter light scattering and DC/AC impedance sensing, and less on cytochemical or 
immuno staining in order to reduce cost, human interaction, and reagent use.  More 
parameters are added into blood count, and a task force initiated by the International 
Society for Laboratory Hematology has formulated an approach to achieve extended 
differential count (EDC), which includes immature granulocytes, reticulocytes (immature 
erythrocytes without nucleus), nucleated erythrocytes, blasts, atypical lymphocytes, and 
hematopoietic progenitor cells [6].  New monoclonal antibody-based flow cytometry 
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methods have been proposed as a new reference method for blood count to replace the 
error-prone and statistically insufficient manual blood count reference method [19, 20]. 
1.2 BioMEMS for cell analysis 
BioMEMS (Bio Micro Electro-Mechanical Systems) is a subset of MEMS 
technology, which generally refers to devices that have at least one dimension in the 
range of ~100 nm to 200 μm [21]. Concisely stated, BioMEMS is the application of 
MEMS fabrication technology to biological and biomedical fields.  The origins of the 
field lie in microfabricated devices for molecular analysis, e.g., capillary electrophoresis 
(CE), gas-phase chromatography (GPC), and high-pressure liquid chromatography 
(HPLC) [22].  After the mid-1990s, polymer plastics, especially poly(dimethylsiloxane) 
(PDMS), replaced silicon and glass as the most popular materials.  Fundamental and 
unique flow properties in microdomains, such as laminar flow without turbulence [23, 24] 
and electro-osmotic driven plugged flow [25], have been exploited.  Just as integrated 
circuits have basic building blocks such as resistors, capacitors, and transistors, an 
analogous set of components, such as valves [26], pumps [27, 28], and mixers[29−31], 
have been demonstrated for microfluidic systems.  Application of bioMEMS systems to 
resolve problems has emerged in areas such as screening conditions for protein 
crystallization [32, 33], high-throughput screening in drug development [34, 35], single 
cell manipulation and analysis [36−39], single molecule analysis [40, 41], and 
microreactor chemical synthesis [42, 43]. 
Cell analysis has been an active area in bioMEMS since its inception.  Recently it 
has been reviewed by several authors [36, 37, 44−46].  In microdevices, the spatial and 
temporal clues for cells can be reproducibly controlled and the heterogeneity of cell 
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population can be studied with single cell analysis.  These new tools create new 
opportunities for research areas, such as cell biology, developmental biology, and tissue 
engineering.   
Microfabricated cell culture devices can mimic in vivo environments by 
patterning the extracellular matrix in 3D and providing nutrients and oxygen gradients by 
microfluidic networks.  Live-cell culture and the study of hepatotoxicity for drugs have 
been of special interest for their potential application in drug discovery [47−49].  Shear 
stress and mechanical loading are important factors to be controlled locally for bone cell 
culture [50].  Adherent cells can be stimulated in microdevices by on-chip gradient 
generators [51−53], while cells in suspension can be stimulated after trapping [54, 55] or 
by using flow segmentation techniques [56].  Cell sorting has been demonstrated based 
on dielectrophoresis (DEP) [57], fluorescence (FACS) [58, 59], or affinity [60, 61].  
Sample preparation for molecular analysis requires cell lysis, which has been 
demonstrated effectively on-chip by several approaches, i.e., chemically with surfactant 
or local hydrogen peroxide generation [62, 63], mechanically by forcing cells through 
nanoscale barbs [64], and electrically by irreversible destruction of plasma membrane 
[65].  PCR or reverse transcription PCR (RT-PCR) are applied to amplify cellular DNA 
or RNA in either flow-through or thermal cycle fashion [66].  Protein and DNA 
fractionation has been achieved with the use of nano-filters [67], but electrokinetic 
separation techniques ⎯ such as capillary electrophoresis (CE), gel electrophoresis, 
electrochromatography, and isoelectric focusing (IEF) ⎯ are more popular [68, 69]. 
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1.3 Fabrication technologies 
In this subsection, two microfabrication technologies used in later chapters are 
introduced.  One is soft lithography.  The other is integrated parylene technology. 
1.3.1 Soft lithography 
Soft lithography is a set of non-photolithographic microfabrication techniques that 
use a patterned elastomer as the stamp, mold, or mask (rather than a rigid photomask) to 
generate micropatterns and microstructures [70].  The pattern transfer process  generally 
contains three steps: (1) fabricating a patterned master, (2) molding the master to generate 
a patterned stamp, (3) generating a replica of the original template in a functional 
material by applying the stamp [71].  Soft lithography can be categorized into replica 
molding, embossing, and microcontact printing.  The fabrication technique used in this 
thesis is replica molding, which refers to transferring topographical features from a rigid 
or elastomeric mold into another material by solidifying a liquid in contact with the 
original pattern. 
The common master material is either made using silicon or SU8 (a UV 
patternable epoxy) on silicon.  Silicon masters can be precisely micromachined using 
DRIE and are widely used in the research community, while SU8 masters are typically 
lower cost and require less-specialized equipment to create. The elastomer most 
commonly used is poly(dimethylsiloxane) (PDMS), which is silicone rubber.  PDMS has 
a number of useful properties:  it is inert to many chemicals (including most inorganic 
solvents), has a low surface energy (γ = 21.6 dyn/cm2) which facilitates its release from 
the master after curing, it is thermally stable below ~ 150 ℃, optically transparent down 
to ~ 300 nm, mechanically tough (tensile modulus of 4.77 MPa), flexible (elastic 
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modulus of 1.8 MPa and elongation up to ~ 160%), and gas permeable.  PDMS is 
considered to be a suitable reference material for the evaluation of the in vitro and in vivo 
biocompatibility of biomaterials [72].  The gas permeable property of PDMS makes it a 
desirable material for applications where gas transport is preferred (e.g., on-chip cell 
culture). 
The general fabrication process used in this thesis is shown in Fig. 1-1. The first 
step in the process: the master (mold) is generated with photolithography on silicon wafer 
using deep reactive ion etching (DRIE).  Then PDMS prepolymers (e.g., Sylgard 184, 
Dow Corning, Midland, MI, USA) are mixed vigorously, degassed, poured over the 
master, and cured in a oven.  After thermal curing, the PDMS is peeled off the mold, and 
cut into individual devices.  The fluidic vias are punched through the material with a 
stainless steel tube.  Finally, the devices are bonded to a clean glass slide or glass wafer 
die.  This procedure can be modified to include multiple layers of PDMS through 
PDMS/PDMS bonding.  Multilayer PDMS structures make the integration of valves and 
pumps relatively simple [73].  The surface of PDMS can be modified physically by 
corona, plasma, or laser treatment, or chemically by surface grafting.  The bulk property 
of PDMS can be modified by blending, copolymerization, interpenetrating polymer 
networks, and functionalization [74]. 
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Figure 1-1 PDMS device fabrication process 
 
The relative ease of processing, biocompatibility, low material and fabrication 
cost, and the previously enumerated properties of PDMS have made the PDMS-based 
soft lithography the most widely used fabrication technology in bioMEMS so far.  Useful 
microfluidic components, such as pneumatic valves and pumps, can be integrated easily 
and reliably, which makes PDMS the key material for exploratory research [75].  Large 
scale fluidics integration has been demonstrated [76, 77]. 
1.3.2 Integrated parylene technology 
Parylene (poly-para-xylylene) was discovered in 1947 and commercialized by 
Union Carbide Corporation in 1965 [78].  Fig. 1-2 shows the chemical structures of the 
most commonly used parylene: parylenes N, C and D.  Ever since its discovery, the 
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number of applications for parylene has grown dramatically in electronics, medical 
devices, the automobile industry, and the military. 
CH2 CH2
Cl
n
Parylene C
CH2 CH2
Cl
n
Cl
Parylene D
CH2 CH2
n
Parylene N  
Figure 1-2 Chemical structures of parylene N, C, and D 
 
The wide application of parylene is due to its rather unique properties (Table 1-3).  
Parylene films are mechanically strong and flexible.  Parylene C has an elongation break 
of 200%, which makes it a good building material for MEMS applications requiring high 
pressure.  Parylene is also an excellent electrical insulator: The electrical breakdown 
voltage of a one micron thick parylene layer is over 200 volts.  It is also an excellent 
thermal insulator: the room temperature thermal conductivity of parylene C is only three 
times as large as static air (0.30 mW/cm-K).  The electrical and physical properties of 
parylene are unchanged when it cycles between room temperature and 2 ºK.  In terms of 
optical properties, parylene is transparent in the visible light range.  However, parylene 
absorbs strongly for wavelengths shorter than 280 nm, which limits some of its UV 
applications. Parylene is an excellent barrier for gas and moisture: the gas permeability of 
parylene is more than four orders of magnitude smaller and the moisture permeability is 
ten times smaller than PDMS.  Parylene is completely inert to most chemicals and 
solvents used in chemical or biological laboratories.  Swelling caused by solvents is 
minor on parylene N, C, and D, with a 3% maximum increase in film thickness, and is 
completely reversible after the solvents are removed by vacuum drying.  Furthermore, 
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parylene is biocompatible (USP Class VI), which makes it one of the few materials best 
suited for long-term human implants.  Parylene thin films are deposited using a room-
temperature CVD process which makes parylene deposition a post-CMOS compatible 
process.  Parylene thin films can be processed by conventional lithography processes and 
oxygen plasma etching in RIE (reactive ion etching) instrument.  The newest 
commercially available parylene, parylene HT from Specialty Coating Systems (SCS), 
provides the highest temperature and UV stability and lowest dielectric and friction 
coefficients. 
Table 1-3 Properties for parylene N, C, D, HT, and PDMS [79, 80]. 
Property Parylene-N Parylene-C Parylene-D Parylene HT PDMS [80] 
Dielectric Strength 
(V/mil), 1 mil film 
7,000 5,600 5,500 5,400 610 [81] 
(1 mm film) 
Dielectric Constant 
60 Hz 
1 kHz 
1 MHz 
 
2.65 
2.65 
2.65 
 
3.15 
3.10 
2.95 
 
2.84 
2.82 
2.80 
 
2.21 
2.20 
2.17 
2.3−2.8  
Young’s Modulus (psi) 350,000 400,000 380,000 ⎯ 52–126  
Index of Refraction 1.661 1.639 1.669 ⎯ 1.4  
Yield Strength (psi) 6,100 8,000 9,000 ⎯ 325  
Elongation to Break (%) 20−250 200 10 ⎯ 210–310 [81] 
Coefficient of Friction 
Static 
Dynamic 
 
0.25 
0.25 
 
0.29 
0.29 
 
0.33 
0.31 
 
0.145 
0.130 
 
⎯ 
0.43−0.51 [82] 
Density (g/cm3) 1.10−1.12 1.289 1.418 ⎯ 9.7*10-4  
Melting Point (℃) 420 290 380 > 450 -49.9–40 
Thermal Conductivity at 
25 ℃ 
(10-4 cal/(cm*s*℃)) 
3.0 2.0 ⎯ ⎯ 3.6  
Specific Heat at 20 ℃  
(cal/g*℃) 
0.20 0.17 ⎯ ⎯ 0.35  
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Fig. 1-3 shows the parylene deposition procedures, the involved chemical 
processes, and the instrument.  The process includes vaporization, pyrolysis, and 
deposition.  Beginning with the stable granular parylene dimmer (di-para-xylylene), the 
material is vaporized under vacuum (8−10 mTorr) and heated to 170 ℃ to form dimeric 
gas.  The gas is then pyrolized to cleave the dimer to its monomeric form at 690 ℃.  In 
the room-temperature deposition chamber, the monomer gas deposits on all exposed 
surfaces as a transparent polymer film (poly-para-xylylene).  Although parylene N 
structure is used in Fig. 1-3, the deposition process is almost identical for all three 
common types of parylene, except for some slight differences in pyrolysis temperature 
and deposition pressure.  The thickness of the parylene coating is controlled by the 
amount of the dimer used.  Typical parylene coating thicknesses in a single deposition 
ranges from 0.1 to 20 μm.  The normal deposition rate of parylene C under a deposition 
vapor pressure of 23 mTorr is about 5 μm per hour.  The deposition rate is directly 
proportional to the square of the monomer concentration in the chamber and inversely 
proportional to the absolute temperature of the substrate on which parylene will be coated 
[83]. 
The room-temperature conformal deposition, the pin-hole-free high film quality, 
the excellent physical and chemical properties and the easiness of processing make 
parylene a good material for MEMS surface micromachining.  Parylene microfluidic 
devices such as channels, pumps/valves, filters, pressure and flow sensors, mass flow 
controllers, electrospray nozzles, and liquid chromatography columns have been 
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successfully demonstrated (Fig. 1-4) [84−89].  The bio-compatibility of parylene makes it 
a perfect material for implantable or bioprocessing devices [90]. 
CH2 CH2
n
Di-para-xylylene
(Dimer)
para-xylylene
(Monomer)
Poly(para-xylylene)
(Polymer)
CH2 CH2
CH2CH2
CH2 CH2
(a)
(c)
(b)
(a) Vaporizer:170 oC
(b) Pyrolysis: 690 oC
(c)Deposition
25 0C
Cold Trap
-70 oC
Vacuum
Pump  
Figure 1-3 Parylene deposition system and the involved chemical processes 
 
 
Figure 1-4 Parylene microfluidic devices.  (Courtesy Dr. Yu-Chong Tai) 
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CHAPTER 2 
BLOOD CELL SEPARATION 
 
2.1 Introduction 
Blood cell (here mainly erythrocyte and leukocyte) separation is an important 
sample preparation step for blood count application.  Due to the large number ratio of 
erythrocytes to leukocytes (approximately 1,000 to 1) and the similarities of their 
properties (e.g., size, electrical impedance, optical scattering cross area), using whole 
blood to achieve whole blood count within clinical significant accuracy range is 
extremely challenging.  Because performing cell count with an unseparated blood sample 
is challenging, conventional automated blood analyzers utilize multiple channels and 
sensors to count different components inside the blood [1, 2].  For example, in most of 
the automated hemocytometers made by Beckman Coulter, Inc., 
(http://www.beckmancoulter.com) erythrocytes are counted in one channel by electrical 
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impedance sensors from diluted whole blood samples.  Leukocytes are counted and 
differentiated into 3- or 5-parts in another channel by a combination of DC and AC 
electrical impedance sensing and/or multi-parameter light scattering with hemolyzed 
blood samples.  Sometimes differential lysing is needed to differentiate basophils from 
the rest of the leukocytes before these basophils are counted in another channel.  Often, 
platelets are counted in one additional channel.  Separating the whole blood sample into 
several subgroups of specific cell types enables the sensitivity of the sensors to be 
significantly improved because the sensors are designed for one specific type of blood 
cell, instead of all the blood cells.  In this chapter, separation of erythrocytes and 
leukocytes are studied in microdomain.  The goal of this research aims specifically to 
develop a simple, reusable, continuous separation method using microfluidics for 
erythrocyte and leukocyte separation without the need for lysing chemicals. 
2.1.1 Blood cell composition and geometrical characteristics 
Human blood cells can be generally classified into three types: erythrocytes 
(RBC), leukocytes (WBC), and platelets.  Leukocytes can be further classified into 
granulocytes, monocytes, and lymphocytes.  Granulocytes can be further classified into 
three categories⎯neutrophils, eosinophils, and basophils⎯depending on their affinity to 
different pH-sensitive dyes.  Table 2-1 compares the geometries and counts of 
erythrocytes and leukocytes in adults.  Because of its shape, the height of a normal 
erythrocyte varies from 1.5 to 3.5 μm [3], and it is clearly smaller than an average 
leukocyte, whose diameter falls between 6 and 20 μm.  This difference in size enables the 
size-based separation of erythrocytes and leukocytes.  Table 2-2 shows the composition 
and geometrical size of leukocytes.  A comparison between Table 2-1 and 2-2 shows that 
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the challenge of size-based separation of erythrocytes and leukocytes can come from the 
size overlap between erythrocytes and the small lymphocytes, which are dominated by T-
lymphocytes. 
Table 2-1 Comparison of human erythrocytes, leukocytes, and platelets [1, 4−6] 
Cell Type Cell Shape Diameter 
Average (μm) 
Diameter 
Range (μm) 
Height 
(μm) 
Count 
(109/L) 
Erythrocytes biconcave disk 8 7−9 1.5−3.0 3.8−5.9×103 
Leukocytes sphere 13 6−20 6−20 4.5−11.0 
Platelets irregular ⎯ 2-4 ⎯ 1.5−3×102 
Table 2-2 Components and size of human leukocytes [1, 5, 6] 
Leukocyte Type Diameter 
Range (μm) 
Absolute Count 
(μL) 
Percentage 
(%) 
Total WBC 6−20 4,500−11,000 100 
Lymphocytes 
(Immunocytes)† 
7−18 1,000−4,000 25−33 
T cells 6−9 800−3,200 80* 
B cells 9−15 100−600 10−15* 
Natural killer ⎯ 50−400 5−10* 
Granulocytes 10−18 3,000−7,500 60−75 
Neutrophils† 13−18 3,000−7,000 59−70 
Segmented 13−17 2,800−5,600 54−68 
Band 16−18 150−600 3−5 
Eosinophils† 12−15 50−400 1−5 
Basophils† 10−14 25−100 0−0.75 
Monocytes† 12−20 100−800 3−7 
†5-part differential measurands  *Percent of total lymphocyte count 
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2.1.2 Conventional cell separation techniques 
Cells can be extremely heterogeneous, and a good example is cells in human 
blood. Although the majority of cells are erythrocytes, a mixture of leukocytes inside 
human blood has very important immunological functions [1].  Even rarer inside blood 
are circulating tumor cells [7, 8] and hematopoietic stem cells [9]. 
Traditionally, biological cells can be separated from the surrounding media and 
each other by different methods.  One of the simplest and common ways is 
centrifugation and ultracentrifugation.  If a tube of collected human blood is kept 
vertical, it can normally be fractionated in 30 to 80 minutes due to specific gravity 
difference.  During this sedimentation process, erythrocytes go to the bottom, while 
leukocytes form the “buffy coat” layer between packed erythrocytes and plasma.  
Density-gradient centrifugation is used to expedite the natural sedimentation process in 
Ficoll-Paque protocol for lymphocyte purification, where erythrocyte agglutination 
reagent Ficoll helps to move erythrocytes down to the bottom of the centrifugation tube 
faster and high-density reagent sodium metrizoate or sodium diatrizoate keeps 
lymphocytes inside the plasma [10, 11].  Another simple method for cell separation is 
size-based filtering.  For example, polycarbonate filters of 8 μm pores made by track 
etching can be used to isolate circulating tumor cells from blood samples with high 
recovery and enrichment [12, 13].  More powerful and perhaps the most important cell 
separation methods are based on immune recognition between antibody and antigen.  
Immunomagnetic separation uses antibody coated magnetic beads to label target cells, 
followed by applying a magnetic field to the sample mixture to capture the cells bound 
to the magnetic beads while eluting out the other cells.  Target cells can be collected by 
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turning off the magnetic field. [14].  Fluorescent activated cell sorting (FACS) is the 
most widely used technique for cell separation.  Target cells are labeled with 
fluorophore-conjugated antibodies before flowing into a flow cytometer.  The flow 
cytometer sorts the cells electrically and/or mechanically based on the fluorescent signal 
[2]. 
2.1.3 Micro scale cell separation 
Recently, there are increasing efforts toward cell separation in microscale.  Field-
flow fractionation is a group of technologies that requires continuous elution.  An electric 
field is placed perpendicular to the fluid flow, which is laminar due to the microscale 
geometry.  Particles are levitated by the field to different stream laminae, and separated 
due to different flow velocity in the parabolic laminar flow profile.  Particles can be 
differentiated by the nature of the field applied.  For example, investigators from 
Giddings’ group use sedimentation field-flow fractionation to separate erythrocytes in 
less than five minutes [15, 16].  In another attempt, Gascoyne’s group uses electrorotation 
to measure cell membrane capacitance of T- and B- lymphocytes, monocytes, and 
granulocytes [17].  The difference of cell membrane capacitance among these cell types, 
according to the single-shell dielectric model, enables separation of T- (or B-) 
lymphocytes from monocytes, T- (or B-) lymphocytes from granulocytes, and monocytes 
from granulocytes in a dielectrophoretic/gravitational field-flow fractionation device[18].  
The same approach also demonstrates separation of cultured human breast cancer MDA-
435 cells from normal blood cells [19]. 
Two magnetic approaches have been applied to blood cell separation in the 
microscale [20].  In one method, the difference of native susceptibility between 
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erythrocytes and other blood cells is exploited.  The most paramagnetic cell in the body is 
the deoxygenated erythrocyte. The approximate 109 iron atoms carried by hemoglobin 
protein in each erythrocyte make the cell paramagnetic, unlike other cells in blood.  Even 
in its oxygenated state, the erythrocytes are less diamagnetic than other blood cells.  Both 
diamagnetic capture mode [21, 22] and paramagnetic capture mode [23] have been 
demonstrated.  The other approach is a more general method using antibody conjugated 
magnetic beads.  CD45-covered micro magnetic beads were used to label leukocytes and 
separate them from blood [24]. 
Several biomimetic microdevices have been demonstrated for cell separation or 
enrichment.  A unique device based on the intrinsic features of blood flow in the 
microcirculation, such as plasma skimming and leukocyte margination, was proposed to 
separate leukocytes directly from whole blood [25].  34-fold enrichment was achieved.  
In another study, a whole blood sample is forced to flow in a lattice of channels designed 
to mimic the capillary channels hydrodynamically.  The leukocytes self-fractionate into 
the different types due to a combination of stretch-activated adhesion of cells with the 
walls, stochastic sticking probabilities, and hetero-avoidance between granulocytes and 
lymphocytes [26].  Chang et al. fabricated an array of square or slender offset pillars 
coated with E-selectin IgG chimera inside microfluidic channels to mimic physiological 
process of leukocyte recruitment to blood vessel walls.  HL-60 and U-937 cells can be 
enriched or partially separated by interaction with the antibody-coated wall of the device 
[27]. 
Acoustic standing wave technology has been demonstrated for continuous particle 
separation in both macroscopic and microscopic domains [28].  It has been applied to 
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continuously separate particles from medium with high efficiency in microchips 
assembled by anisotropic etched silicon chamber with glass lid [29].  Separation of 
erythrocytes from lipid microemboli in whole blood has been reported.  In this case, the 
width of the channel is chosen to correspond to half the ultrasonic wavelength, thereby 
creating a resonator between the side walls of the flow channel in which a standing wave 
can be formed.  Lipid particles are collected in the pressure antinodes by the side walls 
and erythrocytes in the pressure node [30, 31]. 
More closed related to this work are examples that separate cells based on size.  
As shown in Table 1 and 2, the sizes of blood cells are different (leukocytes are larger 
than erythrocytes).  Not shown in these tables is the fact that although there is a diameter 
overlap between erythrocytes and leukocytes (especially T lymphocytes), the volume of 
leukocytes is at least twice of that of a normal erythrocyte due to the biconcave disk 
shape of the erythrocyte [6]. Therefore, a separation of erythrocytes and leukocytes by 
size should use the 3D volume information as part of the criteria, instead of being based 
solely on the largest dimension of the cell.  A microstep device fabricated on silicon was 
shown to separate microbeads of different sizes by physically blocking the larger one 
with the steps [32].  Recently there is a group of devices under the general name of 
hydrodynamic separators that separate particles continuously and passively based on the 
streamline theory inside microfluidic devices.  Sturm’s and Austin’s groups designed a 
device with an asymmetric shifted pillar array and successfully demonstrated separation 
of microbeads in submicron sizes and DNAs of different lengths [33].  Later the 
technology was applied to blood cell separation as described later in this chapter [34, 35].  
Seki’s group demonstrated several designs of channel based hydrodynamic separators 
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[36−39].  In these devices, particles exit into multiple side branch channels determined by 
their center positions relative to the streamlines going into the side channels.  Beads and 
cells of different sizes were separated inside the devices.  Fluidic resistance calculation 
was used to calculate the fluidic width inside the main channel that goes into side channel, 
thus the critical particle sizes. 
In the following sections of this chapter, two size-based hydrodynamic separators 
are presented.  The pillar-shaped separator can separate particles with high resolution, 
while the channel-shaped separator reduces chip footprint significantly and has less 
requirement for flow control. 
 
2.2 Pillar-shaped separator 
2.2.1 Principle 
The device is composed of a separation chamber filled by an array of cylindrical 
pillars as well as inlets and outlets.  Each row of pillars has the same center-to-center 
distance λ and edge-to-edge distance d, and is staggered by a finite displacement from the 
previous row Δλ (Fig. 2-1B).  Because of small channel dimension (on the order of 
10−100 μm) and flow rate (on the order of 0.01−1 μL/min), the Reynolds number (<10-2) 
is in the laminar regime.  Thus the flow inside the device can be treated as 2D laminar 
flow.  For fully developed steady flow, each pillar has two stagnation points.  The 
stagnation points of adjacent rows are rotated with respect to the net fluid flow direction 
because of the row shift.  Separation lanes are defined by division lines, which are 
streamlines ending at stagnation points (Fig. 2-1C).  The special property of the 
separation lines are such that spherical particles with mass centers at the left-hand side of 
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separation lines will flow from the left-hand side of the pillars, while particles at the 
right-hand side of separation lines will flow from the right-hand side.  The critical 
separation size is defined as twice the minimum distance between the edge of pillar and 
the nearest division line.  For a given geometrical design, there is one corresponding 
critical separation size. 
 
 
Figure 2-1 Design of pillar-shaped separator.  (A) Device for blood separation. (B) 
Detailed device structure with geometrics labeled. (C) A small particle moves in zigzag 
mode and a large particle moves in displacement mode with four separation lanes for 
Δλ=λ/4. 
 
When the particles are not interacting with walls, it is assumed they will not 
change the flow pattern and will follow the streamlines.  The interactions between 
particles are also neglected for simplicity of the model.  This is a good approximation for 
blood diluted over ten times, but might not be appropriate for undiluted blood.  If the 
Δλ = λ/4
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diameter of a particle is smaller than the critical separation size, it can follow a separation 
lane exactly resulting in a zigzag flow pattern, which follows the net fluid flow direction 
over a long distance.  On the other hand, if the diameter of a particle is larger than the 
critical separation size, it flows in displacement mode.  The particle does not remain in 
one separation lane all the time, and changes between lanes as it is unable to make 
sudden turns around pillars.  These particles flow diagonally and do not follow the net 
fluid flow direction. 
2.2.2 Experiment 
2.2.2.1 Material 
PDMS (polydimethylsiloxane) (Sylgard 184) was obtained from Dow Corning, 
MI, USA.  Polystryrene beads were purchased from Duke Scientific Corporations, CA, 
USA. 
2.2.2.2 Device design and fabrication 
PDMS is chosen for the device because of its blood compatibility and ease of use.  
Devices are fabricated with DRIE-silicon molds and mounted on a glass slide by 
overnight baking at 80 ℃ (Fig. 2-1A).  The channel height is 20 μm.  The effective 
separation area is 7 mm by 1.8 mm and consists of upstream and downstream regions.  In 
each region, every consecutive row of obstacles is shifted horizontally by a fixed amount: 
4 μm for upstream, 6 μm for downstream.  In both regions, along each row, the center-to-
center distance of obstacles, λ, is 60 μm, while the distance between them, d, is 14 μm.  
At inlet, the blood sample is introduced and focused by two sheath flows. 
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2.2.2.3 Device simulation 
The flow pattern inside the device is simulated by solving a 2D incompressible 
Navier-Stokes equation with FEMLAB.  No-slip boundary conditions are used for the 
device walls.  Also assumed are parabolic velocity field profile at the inlet and zero 
pressure at the outlet.  Fig. 2-2 shows the simulated streamlines for the modeled device.  
The colors are coded for magnitude of the velocity field.  The critical separation size 
derived by simulation is 7.1 μm. 
 
 
Figure 2-2 2D Navier-stokes simulation with velocity field magnitude displayed. 
 
2.2.3 Results and discussion 
2.2.3.1 Device calibration 
Experimentally, the device was first calibrated with polystyrene beads.  Fluids 
were pumped into devices with syringe pumps (Pico Plus, Harvard Apparatus, MA).  
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Central flow rate was kept at 0.2 μL/min and sheath flows were 1.2 μL/min.  Bead 
concentrations were on the order of 103 /μL. 
All beads 5 μm (green) or 7 μm (red) in diameter followed the “zigzag mode.”  In 
contrast, 10 μm (red) diameter beads followed the “displacement mode.”  Finally, the 8 
μm diameter (clear) beads did not strictly follow either mode and exited between the 10 
μm and 7 μm beads (Figs. 2-3 and 2-4).  
To accurately measure the critical separation size and obtain a separation function, 
fluorescent-labeled polystyrene beads (Duke Scientific, CA, USA) are used under 
different flow rates (Fig. 2-5).  Flow rate was found to have little effect on separation 
profile.  The bead size is not uniform.  The measured size distribution of the beads is 
given in Fig. 2-6.  The separation function is calculated by a table lookup operation Fig. 
2-7.  The S shape of the separation function proves the binary nature of the separation, 
validating the use of the device for sorting applications.  The experimentally determined 
critical separation size is approximately 8 μm, which agrees well with the simulation 
result. 
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Figure 2-3 Separation of 5 μm (green), 8 μm (clear), and 10 μm (red) beads 
 
1
1
1
2
2
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Figure 2-4 Statistical analysis of bead separation. Inset is taken with fluorescent 
microscope.  Beads with label 1, 2, 3, and 4 are 5 μm, 7 μm, 8 μm, and 10 μm in 
diameter, respectively. 
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Figure 2-5 Separation profiles under different flow rates 
 
 
Figure 2-6 Measurement of bead size distribution 
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Figure 2-7 Separation function curve 
 
2.2.3.2 Human blood cell separation 
Human blood cell separation was then demonstrated using a blood fraction of 
concentrated leukocytes diluted with Ficoll-Paque Plus (Amersham Biosciences, 
Sweden).  Leukocytes were concentrated by repetitive centrifugation at 1500 rcf (relative 
centrifugation force, equivalent to g) for 10 minutes at 4 ℃, then taking out the top layer 
of supernatant and the bottom layer of pellet.  Ficoll-Paque Plus is a mixture of 
diatrizoate sodium and Ficoll 400.  Ficoll 400 is a neutral, highly branched, hydrophilic 
polymer of sucrose.  Traditionally it has been used as a reagent to purify lymphocytes 
from human peripheral blood based on density gradient centrifugation.  The density of 
the mixture is 1.077 g/mL, which is closer to blood cell density than aqueous saline.  
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Diluting blood with Ficoll-Paque Plus enables us to run an experiment over one hour 
without severe sedimentation. 
The use of a hemacytometer yielded a measured leukocyte-to-erythrocyte ratio of 
1:43.  As shown in Fig. 2-8, two groups of cells following different flow patterns were 
identified.  Statistical analysis concluded that the ratio of cells traveling displacement to 
those traveling zigzag was 1:38 (Fig. 2-9), very consistent with the leukocyte-to-
erythrocyte ratio. 
 
Figure 2-8 Separation of leukocyte (top) from erythrocyte (bottom).  Picture was 
generated by overlaying of multiple video frames. 
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Figure 2-9 Statistical analysis of separation of blood fraction of concentrated leukocytes.  
Left inset is a close up of leukocyte data. Right inset shows one leukocyte (arrow pointed) 
among erythrocytes. 
 
Tests were then performed using a sample of whole blood, diluted with Ficoll-
Paque Plus.  Because of the high erythrocyte-to-leukocyte ratio in natural blood, and 
limitations on flow rate and blood cell concentration, tests were run for over two hours in 
order to observe several leukocytes.  Statistical analysis showed the ratio of cells 
traveling displacement to zigzag to be 1:502 (Fig. 2-10), which is in agreement with the 
known leukocyte-erythrocyte ratio.  However, towards the end of such tests, several 
erythrocytes flowing in zigzag mode appeared in the lanes normally occupied by cells 
flowing in displacement mode.  Such phenomena are believed to be caused by the 
increased amount of blood cells adhering to the obstacles after a long testing time. 
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Figure 2-10 Statistical analysis of separation of diluted whole blood sample. Inset is a 
close up of leukocyte data. 
 
To confirm that most leukocytes flow in displacement mode and estimate 
separation efficiency, we obtained leukocyte-rich plasma by gravity sedimentation of 
erythrocytes in Wintrobe tubes and stained the leukocytes with acridine orange 
(Molecular Probes, OR, USA), before resuspension in Ficoll-Paque Plus.  Acridine 
orange is a nuclear fluorescent dye.  Erythrocytes, which have no nucleus, do not 
fluoresce, only leukocytes are stained and fluoresce.  Fig. 2-11 shows the separation 
profile.  As expected, most of the leukocytes are found to flow in displacement mode (Fig. 
2-11 inset).  The fraction of leukocytes with displacements overlapping erythrocytes is 
9%, indicating a small separation error or high leukocytes separation efficiency of 91%. 
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Figure 2-11 Separation profile of stained leukocyte rich plasma.  Insert is an event of 
leukocyte flow through the detection region. 
 
2.3 Channel shaped separator 
2.3.1 Principle 
The principle of the channel-shaped separator device is based on streamline 
engineering in the separation region.  For the dimension of the device and the flow rate 
used in testing, the Reynolds number is on the order of 10-2.  The flow inside devices falls 
into the low Reynolds number laminar flow regime.  Thus the center of particles can be 
assumed to follow streamlines of the fluidic field if there are no interactions between the 
particle and the channel wall, and the particle concentration is low enough that particle-
particle interaction can be ignored.  The separation principle of the device can be 
illustrated with a T-shape channel in which a side channel branches out from main 
channel (Fig. 2-12 top).  In Fig. 2-12 bottom, the crossing region of the T-shape channel 
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is illustrated with 2D fluidic simulation of undisturbed streamlines.  The flow is from 
right to left and top to bottom.  A stagnation point can be identified, which is normally 
very close to the downstream vertex of the device wall.  At this point, the flow has zero 
velocity.  From this stagnation point, a division line can be drawn that separates the fluid 
region into two parts.  The vertical distance between the division line and device wall at 
the upstream vertex of the side exit channel defines the critical particle size, R, for 
separation.  The collection zone is defined by the area between the division line and the 
device walls, including the side channel.  
As the first step, when particles flow into the crossing region of the T-shape 
channel, they are somehow forced to flow along the bottom channel wall, as in Fig. 2-12.  
When there is no interference from the wall, the particle will flow along the same 
streamline.  The particle-device wall interaction might change the center of a particle to a 
new streamline.  The particle may flow into main outlet or side channels without 
interaction with the downstream channel wall.  If it collides with the downstream channel 
wall, the vertical component of the velocity vector at the center of the particle determines 
whether it goes into a side or the main outlet channel.  For a particle whose radius is 
smaller than the critical particle size R, its center always stays inside the collection zone, 
thus it flows into a side channel.  For a particle whose radius is larger than R, its center is 
above the division line at the upstream vertex and hence it never enters the collection 
zone afterwards. 
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Figure 2-12 Principle of channeled shaped separation.  Top drawing shows the T-shape 
channel with crossing region labeled by a box.  Bottom drawing is a detailed illustration 
of the boxed area.  Background is 2D fluidic field simulation with color coded 
streamlines.  The flow is from right to left, top to down.  Stagnation point, division line 
and collection zone are labeled.  Also labeled is the upstream vertex, where the critical 
particle size for separation R is defined.  Length of side channel L and vertical distance 
between downstream and upstream vertices of side channel walls Δλ are shown.  Traces 
of two particles with radius larger than R (orange color) and smaller than R (green 
color) are also illustrated with black dash lines. 
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2.3.2 Simulation 
The separation is determined by the critical particle size R.  Two factors that can 
be used to control R were studied.  The T-shape channel served as our model.  The 
effects were studied by a 2D FEMLAB simulation of the Navier-Stokes equation.  
Aqueous solution was simulated as flowing inside the device.  A parallel velocity profile 
with maximal velocity of 1 mm/sec was applied at the inlet.  Zero pressure was used for 
outlets.  The no-slip condition was assumed at the device walls.  If not specified 
otherwise, 1000 μm was used as the channel length for the inlet channel, the main outlet 
channel, and side branching channels.  100 μm was used as the channel width for both the 
inlet and main outlet channel.  10 μm was used as the channel width of the side channels. 
First, the effect of the length of side channel L is examined.  As the solid line in 
Fig. 2-13 shows, increasing side channel length decreases critical particle size.  This is 
caused by greater fluidic resistance in the side channel and hence a reduced flow rate in 
the side channel.  For low Reynolds number flow in a long tube, the pressure difference is 
proportional to flow rate.  The ratio of pressure difference and flow rate defines fluidic 
resistance.  In 2D geometry, fluidic resistance can be expressed as 
31
12
WR
Lμ=  
where W is channel width, L is channel length, and μ is fluid viscosity.  The T-shape 
channel, the main inlet, main outlet, and side channel outlet were modeled as three 
resistors by applying the fluidic resistance equation.  The fluidic resistance of the main 
outlet was in parallel with that of the side channel so the product of fluidic resistance and 
flow rate of the main outlet equals that of the side channel.  From the flow rate ratio of 
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the main outlet and side channel, and assuming a parabolic flow profile of the velocity 
field in the main inlet, the width of fluid in the main inlet channel that went into the side 
channel was calculated.  The result was plotted in Fig. 2-13 as a dash line.  The values 
calculated with the fluidic resistance model were always larger than those obtained by 
simulation.  This is because only at upstream far from the upstream vertex (where the 
critical particle size was defined) could the parallel velocity profile be assumed.  
Therefore, the critical particle size calculated by the fluidic resistance model was the 
distance between the division line and the main channel wall far upstream of the 
upstream vertex.  This was confirmed by simulation.  From the simulation, the distance 
measured between division line and main channel wall far upstream matched well with 
the results from the fluidic resistance calculation. 
The other factor considered was the local geometry of the crossing region.  In this 
case, the vertical distance between downstream and upstream side channel vertices Δλ 
was used as a design parameter.  As in Fig. 2-14, critical particle size R increased as 
Δλ increased and was more sensitive when Δλ was positive. 
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Figure 2-13 Simulation study of the effect of side channel length L on critical particle 
size R.  Solid line is 2D Navier-Stokes simulation results.  Dash line is critical particle 
size calculated from flow resistance model. 
 
.  
Figure 2-14 Simulation study of the effect of side channel edge distance Δλ on critical 
particle size R.  Positive Δλ is defined as inset. 
   
 
 
53
2.3.3 Device design 
Two devices were designed, fabricated, and tested.  For device I, only the effect 
of local geometry change was tested.  Side channel length L was kept the same for all 
side exit channels, and only the vertical distances Δλ of downstream and upstream 
vertices of side channels were changed.  To optimize the device for blood cell separation, 
in device II, both L and Δλ were changed to achieve a wider range of critical particle 
sizes. 
The devices contained one sample inlet, one buffer inlet, one main outlet, and 
multiple side channel outlets (Fig. 2-15 and Fig. 2-16).  Three side channels with the 
same local geometry were grouped into one downstream channel.  There are eleven 
groups in device I and ten in device II.  After sample flow met buffer flow, the sample 
flow was squeezed by the buffer flow in the pinch flow region.  Relative flow rates were 
adjusted so that all particles in the sample flow pinched against the main inlet channel 
wall before they entered the separation region.  The pinch flow region was 500 μm long 
so that the flow was stabilized before it entered the separation region.  The separation 
region consisted of an array of side exit channels perpendicular to the main channel, each 
with a corresponding critical particle size. 
The eleven groups of side exit channels on device I increased in Δλ from -5 μm to 
5 μm in 1 μm increments when considered from upstream to downstream.  Simulation 
from the T-shape channel model predicted the critical particle size for each of them, as 
shown in Fig. 2-17.  From side channel group numbers one to eleven, the critical particle 
size changes from 2.9 μm to 3.8 μm. 
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Figure 2-15 Design of channel-shaped separation device I 
 
 
Figure 2-16 Design of channe- shaped separation device II 
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Figure 2-17 Prediction of critical particle sizes for different side channel groups in 
device I 
 
To optimize the device for blood cell separation, a device with larger span of 
critical particle size is desirable.  Erythrocytes average 8 μm in diameter and can range 
from 7 μm to 9 μm.  Leukocytes have a wider range from 6 μm to 20 μm.  The ratio of 
erythrocytes to leukocytes in whole human blood is in the magnitude of thousands to one.  
For device II, from upstream to downstream, Δλ increases from 0 μm to 9 μm in 1 μm 
increments and the length of the exit channels decreases linearly from 22000 μm to 2200 
μm in a -2200 μm increment.  The critical particle sizes increase from upstream to 
downstream, as predicted by FEMLAB (Table 2-3).  From side channel group 1 to 10, the 
critical particle size increases roughly exponentially.  This is desirable, since the majority 
of the cells in blood fall into the lower size range.  With this design, the separation is 
finer for smaller particles and rougher for large ones.  Fig. 2-18 shows the fluidic 
simulation of the crossing regions of side channel 1, 6, and 10, overlaid with spherical 
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particles of radii from 1 μm to 10 μm.  At the upstream vertex, where a particle loses its 
contact with the device wall, its center position is compared against the division line.  
The particle might flow into a side channel without interaction with the downstream 
device wall, as is the case for particles 1 and 2 in Fig. 2-18a.  It might collide with the 
downstream vertex of the device wall as do particles 4 to 10 in Fig. 2-18a or the 
downstream device wall as do particle 3 in Fig. 2-18a, particles 4 and 5 in Fig. 2-18b and 
particle 10 in Fig. 2-18c.  Depending on its center position relative to the division line, 
the particle will moved into the main channel or side channel.  Particles 4 and 5 in Fig. 2-
18b are interesting cases, where the particles collide with the side channel wall but the 
fluidic drag force moves them up into the main channel. 
Table 2-3 Design parameters and predicted critical particle sizes for device II 
Side Channel Group 
Number 
Side Channel 
Length L (μm) 
Edge Distance Δλ 
(μm) 
Critical Particle 
Size R (μm) 
1 22000 0 2.28 
2 19800 1 2.57 
3 17600 2 2.88 
4 15400 3 3.08 
5 13200 4 3.54 
6 11000 5 4.12 
7 8800 6 4.79 
8 6600 7 5.76 
9 4400 8 7.39 
10 2200 9 10.75 
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Figure 2-18 2D fluidic simulation at the crossing region of side channels of device II.  
Spherical particles with radii from 1 μm to 10 μm with 1 μm increments were also drawn 
to illustrate their trajectories.  Each particle is shown twice.  One is at the moment when 
it is about to lose contact with the upstream vertex of the device wall.  The other is when 
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it is closest to the downstream device wall.  The direction of the undisturbed velocity field 
at the center of the particle is labeled with an arrow.  A: side channel number 1, B: side 
channel number 6,  C: side channel number 10. 
 
2.3.4 Fabrication and testing setup 
2.3.4.1 Device fabrication 
PDMS was chosen for the device because of its blood compatibility and ease of 
use.  The mold for PDMS was fabricated by Deep Reactive Ion Etching (DRIE) on 
silicon wafer with photoresist AZ4620 as a mask.  The channel height for device I is 40 
μm and that of device II is 20 μm.  HMDS (1,1,1,3,3,3-hexamethyldisilazane) was used 
to treat the mold before applying a homogenous mixture of PDMS part A and part B 
(10:1).  PDMS was cured in the mold at 80 ℃ for 25 minutes.  Then it was separated 
from the mold, cut into pieces, and holes were punched on each piece with a Luer stub 
adapter (gauge 20, Becton Dickinson, NJ, USA).  PDMS pieces were then ultrasonically 
cleaned in acetone for 10 minutes, and rinsed with acetone, then IPA.  Finally PDMS 
pieces were mounted on clean glass slides by overnight baking at 80 ℃. 
2.3.4.2 Material 
PDMS (polydimethylsiloxane) (Sylgard 184) was obtained from Dow Corning, 
Midland, MI, USA. Polystyrene beads were purchased from Duke Scientific 
Corporations, Fremont, CA, USA.  Wintrobe tubes of 115 mm long and 3 mm inner 
diameter were purchased from Chase Scientific (R828B, Rockwood, TN, USA).  Fresh 
human blood was obtained from healthy donors with anticoagulant EDTA added.  Blood 
samples were used within 48 hours of withdrawal.  Leukocyte-rich plasma was prepared 
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with Wintrobe tubes.  One milliliter of bubble-free fresh whole blood was filled into the 
tube.  The tube was laid on flat surface for thirty minutes to an hour.  Then it was 
gradually tilted up to a vertical position.  The upper, clear, plasma part was carefully 
transferred to a clean container. 
2.3.4.3 Device calibration and testing setup 
Calibration of device I and device II were accomplished with fluorescent 
polystyrene beads of 5 μm and 10 μm in diameter.  Sample flow rate was kept at 0.06 
μL/min, while buffer flow was in the range of 0.5−0.8 μL/min.  The interface of the 
sample flow and buffer flow could be clearly observed under microscope.  The buffer 
flow rate was adjusted so that a desirable flow profile of the interface was achieved.  To 
minimize the effect of bead-to-bead interaction, total bead concentration was on the order 
of 100/μL. 
Flows were introduced into the device by syringe pumps (pump 11 Pico Plus, 
Harvard Apparatus, MA, USA).  The separation region of the device was observed under 
a fluorescent microscope (Nikon E800, Japan) during the whole testing period.  A CCD 
camera (Spot RT slider, Diagnostic Instruments, MI, USA) was connected to the 
microscope and used to take videos.  Videos were later analyzed frame by frame. 
Human blood cell separation was demonstrated using a blood fraction of 
concentrated leukocytes diluted with Ficoll-Paque Plus (Amersham Biosciences, 
Sweden) in device II.  Ficoll 400 is a neutral, highly branched, hydrophilic polymer of 
sucrose.  Its density is 1.077 g/mL, which is closer to blood cell density than aqueous 
saline.  Diluting blood with Ficoll-Paque Plus enables us to run an experiment over one 
hour without severe sedimentation.  Human blood cells were prepared by the 
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sedimentation-based Wintrobe method.  The erythrocyte portion was diluted 1500 times 
with Ficoll-Paque Plus. 
2.3.5 Results and discussion 
The result of separation of 5 μm and 10 μm beads in device I is summarized in 
Fig. 2-19.  All 5 μm beads exit from side channel group number one to three, with 
number one capturing the most.  This corresponds to Δλ of -5 μm, -4 μm, and -3 μm, and 
the predicted critical particle size is in the range of 2.9 μm to 3.0 μm.  Approximately 
50% of 10 μm beads exit from the main outlet as predicted by the simulation of critical 
particle size; the rest flow into the side exit channels.  Assuming side channels one to 
three are collection channels for 5 μm beads, and the rest of the exit channels are 
collection channels for 10 μm beads, the separation efficiency is 97% for device I.  Bead 
counts were normalized for the efficiency calculation. 
In device II, 5 μm green beads exit mainly from side channel groups one and two, 
which correspond to edge distances Δλ of 0 μm and 1 μm, and side channel lengths L of 
22000 μm and 19800 μm (Fig. 2-20).  The predicted critical particle sizes were 2.28 μm 
and 2.57 μm, which matched well with the average radius of the particles.  10 μm red 
beads exit mainly from side channel groups nine and ten, which correspond to edge 
distances Δλ of 8 μm and 9 μm, and side channel lengths L of 4400 μm and 2200 μm.  
The predicted critical particle sizes were 7.39 μm and 10.75 μm (Fig. 2-21).  If 5 μm 
beads were assumed to exit from exit groups one to three and 10 μm beads from groups 
four to ten, a histogram of the separation profile showed the separation has an efficiency 
of 96% (Fig. 2-22). 
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Figure 2-19 Separation profile of 5 μm and 10 μm polystyrene beads in device I.  Exit 
channels numbered 1 to 11 are side exit channels.  Exit channel 12 is the main exit 
channel. 
 
Figure 2-20 Typical trace of 5 μm fluorescent polystyrene beads in device II 
   
 
 
62
 
Figure 2-21 Typical trace of 10 μm fluorescent polystyrene beads in device II 
 
 
Figure 2-22 Separation profile of 5 μm and 10 μm beads in device II 
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There are some discrepancies between predicted critical particle sizes and the 
separation profile for large beads of 10 μm diameter.  In device I, according to the 
simulation, all 10 μm beads should exit from the main outlet.  However, in our 
experiments, about 50% of the large beads exit from side channel groups six to eleven.  
In device II, the simulation predicted most of the 10 μm diameter particles would exit 
from side channel group eight.  However, in our experiments, they mainly exited from 
side channel group nine and ten.  These discrepancies could be due to the coupling effect 
of side exit channels, which was not considered in T-shape simulation, and/or to the size 
variation of the 10 μm beads (up to 15%).  Other factors, such as flow fluctuation caused 
by syringe pumps, adhesion of particles to the device wall, and the difference between 2D 
fluidic simulation and 3D device operation could contribute to the discrepancies.  In 
general, device II demonstrated a better separation profile for 10 μm particles.  In that 
device, the step sizes of critical particle sizes for larger particles are larger, and so are the 
error tolerances. 
For both devices, it was observed under the microscope that the 10 μm beads flow 
in a “jumping” mode in the separation region: they move towards the stagnation points 
close to the downstream vertexes and slow down.  After passing these stagnation points, 
they quickly flow toward the next side exit channel.  Also observed were cases like 
particles 4 and 5 in Fig. 2-18B, where the beads collided with the side channel wall, but 
were moved up by surrounding fluid and entered back into the main channel to exit. 
Erythrocyte and leukocyte separation from diluted human blood was performed 
with device II.  Erythrocyte behavior inside the device was studied with whole human 
blood diluted one thousand times.  Erythrocytes exited mainly from exit channel groups 
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two and three (Fig. 2-23).  To study leukocyte flow inside the device, leukocyte-rich 
plasma was prepared with a final concentration of leukocytes in the range of 102/μL and 
an enrichment factor of leukocytes to erythrocytes in the tens to hundreds range.  
Leukocytes were stained with the fluorescent cell nucleus dye, acridine orange.  Since 
erythrocytes do not contain nuclei, only leukocytes are stained by acridine orange.  As 
shown in Fig. 2-24 and 2-25, the leukocytes demonstrated a different separation profile 
than the erythrocytes.  Not shown in Fig. 2-25, one leukocyte exiting from the main outlet 
during testing was also observed. 
 
 
Figure 2-23 Typical trace of erythrocyte in device II as pointed by arrow.  Images were 
extracted from video with bright field illumination and then overlaid. 
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Figure 2-24 Typical trace of leukocyte in device II.  Images were extracted from video 
with both bright field and Epi fluorescent illumination and then overlaid. 
 
Figure 2-25 Separation profile of erythrocytes and leukocytes in leukocyte- rich plasma 
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If a line was drawn between exit groups three and four with the assumption that 
erythrocytes exited from group numbers one to three and leukocytes exited from the rest, 
a separation efficiency of 97% was achieved, meaning that with inputting equal numbers 
of erythrocytes and leukocytes, over 97% of the cells in exit groups one to three are 
erythrocytes, and the same for leukocytes in exit groups four to ten.  The portion of the 
separation profile where erythrocytes and leukocytes did not separate very well was 
likely caused by the size overlap between erythrocytes and small lymphocytes.  Although 
the volume of average small lymphocytes is at least twice that of erythrocytes [40, 41], 
the size is the determinant factor for the separation inside this device.  Diameters of 
erythrocytes are reported between 7.5 to 8.5 μm, while those of small lymphocytes 
between 6 to 9 μm [1, 4, 6].  On the other hand, because of the biconcave disk shape of 
erythrocytes, their heights range from 1.5 to 3.0 μm, which are substantially smaller than 
the average diameter of small lymphocytes.  Therefore, the separation of erythrocytes and 
small lymphocytes inside the device depends heavily on the orientation of erythrocytes in 
the separation region.  In testing, a large percentage of erythrocytes with the flat portion 
of the disk shape aligned to the device wall were observed before they entered the 
separation region.  It will be beneficial to increase device height so that the shear stress of 
fluid can align the erythrocytes along the device wall and the comparison of their heights 
to critical particle size will determine into which side channel they flow. 
There are several benefits offered by these devices.  The filtering effect of the 
device was achieved by the collection zone formed by the fluidic field, not by physical 
size limitation.  Also this filtering effect was in the direction perpendicular to flow 
direction.  These greatly reduce clogging.  The separation regions of the devices had a 
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very small footprint of 1.5 mm by 0.8 mm.  Setting up fluidic resistance of the side 
channels could take up a lot of chip space.  Local geometry design of the separation 
region and reducing the effective cross-section area of the side exit channels could reduce 
the required length of side channels.  Particles of different sizes were collected in 
different reservoirs that connected to side channels.  This could facilitate further 
characterization of the particles.  The solvent of sample flow went into upstream side 
channels.  This means larger particles, which exited from downstream side channels or 
the main outlet, flowed out with the solvent in the buffer flow, which made solvent 
change for larger particles possible. 
Flow control could be a problem for the operation of the device.  Stable fluidic 
fields are required.  Disturbance from pumps, particle adhesion to device walls, and 
particle-fluid and particle-particle interactions could change the local flow and thus 
change the separation profile.  A multiple port injector structure was designed in the 
buffer flow inlet, so that the buffer flow channel was wide and the flow was stable and 
laminar.  Another problem for device operation was particle adhesion to the device wall, 
which degraded device performance, especially in testing with leukocyte-rich plasma.  
Plasma protein could build up on the device surface.  Platelets and blood cells were 
observed to adhere to the device wall gradually.  This process is related to the freshness 
of the blood sample.  For fresh blood withdrawn within 24 hours, it could take more than 
one hour before significant biomass built up inside the device under our testing 
conditions.  For aged blood samples older than three days, the effect showed up within 
half an hour of device operation.  Surface treatment and dynamic coating could improve 
the situation. 
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2D Navier-Stokes fluidic dynamics simulation was used for critical particle size 
prediction in device design.  From Fig. 2-13, even in cases where only the lengths of side 
channels change, using simulation was more accurate than using a fluidic resistance 
model for critical particle size prediction.  This was because the critical particle size was 
determined by local streamlines at the crossing region, which is closely related to the 
local geometrical design.  This is not considered in the fluidic resistance model.  For 
devices with local geometry variations (Δλ), streamline-based design with simulation has 
to be used to predict the critical particle sizes.  Although the testing results later showed a 
good match between 2D fluidic simulation and testing results, the 3D nature of the 
channels may have some effects on particle separation.  Ideally for very deep channels, 
the parallel velocity profile of the fluid and the resultant shear stress will keep particles of 
similar size in the same layer of fluid.  This can make the flow effectively 2D.  Making 
high-aspect ratio channels could be a problem in device fabrication, and in our PDMS on 
glass devices, the aspect ratio is under two. 
Assuming a particle follows the same streamline in low Reynolds number laminar 
flow is a simplification used in our design.  The actual particle trajectory is more 
complicated.  The flow shears on the particles, the rotation of particles, and the non-
spherical shapes of particles contribute to the transverse lift acting on particles [42].  In 
the case of blood cells, they have been reported to be kept away from capillary walls [43]. 
 
2.4 Conclusion 
Two types of microdevices were designed and demonstrated to separate 
erythrocytes and leukocytes from diluted blood sample based on sizes.  The 
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hydrodynamic separation is continuous, passive, and highly efficient.  Assuming the 
particles in the size range of one micron to tens of microns move along the streamlines in 
the laminar flow devices, a streamline theory was developed to successfully predict the 
critical particle separation size. 
For the pillar-shaped devices, separation of leukocytes from erythrocytes based on 
deterministic lateral displacement principle was demonstrated.  Fluorescent beads of 5 
μm, 7 μm, 8 μm, and 10 μm were successfully separated.  Simulation of 2D laminar flow 
inside the device calculates velocity field and predicts the critical separation size for the 
current design to be 7.1 μm.  The critical particle size for separation was shown to be 
around 8 μm experimentally, which could be used for rough separation of blood cells.  
The ratio of blood cells following displacement mode to those in zigzag mode matches 
with the leukocyte-to-erythrocyte ratio.  Labeled leukocyte experiments confirm the 
separation of the two groups of cells is actually mainly erythrocytes and leukocytes.  The 
efficiency for leukocyte separation is about 91%. 
For the channel-shaped devices, a streamline-based design of microfabricated 
devices was presented to achieve particle separation by size.  2D Navier-Stokes 
simulation was used to predict the critical particle size for separation, which was the 
parameter that determined the binary nature of the separation.  Two devices were 
designed and fabricated.  Both of them separated 5 μm and 10 μm diameter polystyrene 
beads efficiently.  The second device also demonstrated effective separation of human 
erythrocytes and leukocytes.  It had a wider range of critical particle sizes with finer 
separation for small particles.  This made it better suited for human blood cell separation.  
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CHAPTER 3 
ELECTRICAL IMPEDANCE SENSING 
FOR BLOOD COUNT 
 
3.1 Introduction 
3.1.1 Coulter principle 
Electrical impedance sensing has been used to measure biological materials, such 
as tissue samples and cell suspensions, for over a hundred years [1, 2].  Based on the 
Coulter counter principle, electrical impedance sensing has been one of the preferred 
technologies for particle sensing and counting.  The Coulter counter was invented by 
Wallace H. Coulter in the late 1940s [3] and the first U.S. patent was secured in 1953.  
Since then, it has undergone extensive improvements (Fig. 3-1), including adding AC 
impedance sensing in addition to DC resistance sensing; automatic parallel sample 
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handling; improving sensitivity, specificity, and efficiency of WBC differential; and 
improving reliability of quality control. 
The Coulter principle is illustrated in Fig. 3-2.  Two fluidic chambers are 
separated by an aperture.  The size of the aperture is comparable to the size of the 
particles (e.g., beads, biological cells, pollens) to be sensed.  The particle is forced to 
flow from one chamber to the other.  At the same time, the system impedance is 
measured by a pair of electrodes placed in each of the two chambers.  The small feature 
size of the aperture makes it the dominant part of the system impedance.  As a particle 
travels through the aperture, the impedance change is recorded.  Therefore, the existence 
of the particle and some of its properties (e.g. volume, cell membrane capacitance) can be 
determined.  Later, the initial DC resistance sensing was extended to AC impedance 
sensing [2].  
Miniaturization can potentially improve device performance.  The resistance 
change can be increased by reducing the size of the sensing region (aperture) of the 
sensor.  In DC or low frequency AC (f < 100 kHz) cases, assuming a uniform electrical 
field in the sensing region, spherical particles, a cylindrical aperture, and ignoring 
electrical resistance inside the chambers from aperture to electrode, the resistance change 
ΔR is: 
2 2
22 2
arctan
2
r
rR rR
RR r
ρ ππ
⎧ ⎫⎛ ⎞⎪ ⎪⎜ ⎟⎪ ⎪−⎝ ⎠Δ = −⎨ ⎬−⎪ ⎪⎪ ⎪⎩ ⎭
 , (3.1) 
where r represents the radius of the particle, R the radius of the aperture, and ρ the 
resistivity of the medium.  As shown in Fig 3-3A, shrinking the aperture dimension 
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greatly increases the resistance change, which is proportional to the signal being sensed.  
Fig3-3B shows that the channel resistance changes more significantly when the size of 
the particle is approaching the size of a given aperture of fixed size. 
 
 
Figure 3-1 Conventional automated hemacytometers.  Left picture is one of the earliest 
models of DC Coulter counter (Coulter Electronics, Inc.).  Right picture is a modern 
model (COULTER® LH780) with full automation for complete blood count (Beckman 
Coulter, Inc., 2006). 
 
 
Figure 3-2 Principle of Coulter counter 
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Figure 3-3 Relationship of channel resistance change to channel radius and particle 
diameter.  (A) Channel resistance change of the same particle (particle radius 5 μm) in 
devices of different size, assuming electrolyte resistivity of 0.83 Ωm. (B) Channel 
resistance change of particles of difference sizes in the same device, assuming aperture 
across section area of 280 μm2 and electrolyte resistivity of 0.83 Ωm. 
 
Another benefit of miniaturization is reducing the error rate caused by the 
coincidence effect.   The coincidence effect, when two or more particles flow through 
aperture at the same time, can be modeled by a Poisson process.  The relationship of true 
count N and observed count n is: 
(1 )
V N
VVn e
V
Δ−= −Δ ,  (3.2) 
where V is the sample volume and ΔV is the aperture volume.  Reducing the dimension of 
the sensing zone improves the error rate greatly, as shown in Fig. 3-4. 
 
(A) (B)
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Figure 3-4 The relation between error rate and sensing zone dimension, assuming cubic 
sensing zone, sample volume 500 μL and true count 250,000.  The error rate is defined as 
(n-N)/N×100%. 
 
3.1.2 Cellular model for impedance response 
Traditionally when biological tissues and cell suspensions are measured over a 
frequency range of 1 Hz to 10 GHz with a parallel plate capacitive sensor or its 
derivatives, three distinct dispersions, or relaxations, are found in an idealized case of 
dielectric spectra.  α-dispersion, which is under a few kHz, is normally due to the double-
layer effect of the electrodes, and is believed to originate from the displacement of 
counter ions surrounding charged membranes.  β-dispersion, which is between 100 kHz 
and 10 MHz, is due to the interfacial polarization of the insulating plasma membrane 
surrounding the cells.  Above 1 GHz, there is γ-dispersion, which results from 
reorientation of water molecules.  Between the β- and γ-dispersions there may be small 
dispersions resulting from relaxation of biopolymers and bound water [2, 4]. 
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A single biological cell can be modeled either by the single-shell model or one of 
the composite-cell models.  The single-shell model assumes the cell is bound by a plasma 
membrane and that the interior of the cell is homogeneous.  It has been successfully 
applied to mammalian erythrocytes, which have organelles, a complicated cytoplasm 
structure, and no cell nucleus [5].  Composite-cell models include additional material 
layers inside the plasma membrane.  For example, a double-shell model has been used to 
model a large membrane bound cell nucleus in lymphocytes [6], while a double-shell 
model with vesicles has been used to model additional vacuoles and chloroplasts of plant 
cells [7].  Measurement of single-cell impedance spectra by electromechanical methods 
such as dielectrophoresis or electrorotation shows that at low AC frequency (under 100 
kHz) the signal is determined mainly by the cell volume, while at higher frequency (100 
kHz to 10 MHz), the intracellular structures also contribute to the overall measured 
impedance and become explorable measurands [3]. 
3.1.3 Problem of double-layer impedance for microdevices 
The principle of impedance particle sensing relies on the momentary change of 
electrical impedance as particles replace electrolyte in the sensing zone.  This impedance 
change is measured by a pair of electrodes separated by the aperture.  This measurement 
allows for the determination of the presence of a biological cell and provides information 
on some of its properties.  Traditional electrical impedance sensors, however, require a 
large electrode area to reduce the electrode-electrolyte interface (double-layer) 
impedance and allow the channel impedance (including electrolyte impedance and 
particle impedance) to dominate the overall impedance.  Macroscopic blood counters, for 
example, use macro-electrodes, such as platinum wires, to measure the impedance change 
   
 
 
83
across an aperture whose size is in the range of hundreds of microns.  However, this 
presents a major difficulty associated with micro impedance sensing.  The double-layer 
impedance, in series with the channel impedance, is inversely proportional to the 
electrode surface area so downsizing of the electrode area unavoidably increases its 
impedance and reduces the overall sensitivity [8, 9].  This problem is more serious in the 
low-frequency range, where the double-layer capacitance dominates over the channel 
impedance.  In the high-frequency range, the parallel stray capacitance resulting from 
nonideal isolation between electrodes dominates the system impedance.  Hence, the 
system impedance is not sensitive to channel impedance change in either the low or high 
frequency range.  Only in some intermediate frequency range will the channel impedance 
be the dominate component in the system impedance. 
3.1.4 Previous implementation of micro electrical impedance sensors 
For micro DC Coulter sensors, several groups have attempted to solve the large 
double-layer impedance problem by using very large thin-film electrodes [10], 
macroscopic gold pin electrodes [11], or nonpolarizable Ag/AgCl electrodes [12].  For 
micro AC impedance sensors, the double-layer impedance is reduced at a high exciting 
frequency.  Unfortunately, there is an upper limit on the operation frequency imposed by 
the stray capacitance between sensing electrodes, which results from coupling and non-
ideal isolation.  So to study particles with AC impedance sensing, the device is limited to 
a frequency range which is high enough to bypass electrode double-layer impedance and 
low enough that the stray capacitance does not play a significant role in overall system 
impedance [13].  One way is to increase the electrode surface area to reduce the double-
layer impedance so that the sensing can be performed at a lower AC frequency.  H. E. 
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Ayliffe and his coworkers demonstrated AC impedance measurement of cell suspensions 
and trapped cells with very thick (4 μm) electroplated gold microelectrodes [14].  In this 
chapter, electroplated platinum black on microelectrode surface is shown to reduce 
double-layer impedance by two orders of magnitude.  With these electrodes, human 
blood cell sensing with a high signal-to-noise ratio was achieved [15]. 
A second, complimentary approach is to reduce the stray capacitance so that 
sensing can be accomplished at higher frequency.  Gawad et al. reduced the stray 
capacitance down to 0.5 pF and achieved sensing at a high-frequency range between 100 
kHz and 10 MHz [13, 16].  Generally speaking, high-frequency AC impedance sensing 
requires more consideration in electrode design, chip isolation, signal conditioning, and 
processing.  In this chapter, an innovative approach to extending the AC impedance 
sensing range to higher frequencies is also proposed and demonstrated.  It uses an 
external parallel inductor for induced resonance impedance sensing.  The inductor 
cancels out the capacitive components in the system and improves sensitivity 
significantly.  In the following sections of this chapter, a platinum black electroplated 
micro impedance sensor is first presented, followed by a discussion on the inductor-
induced resonance impedance sensing method. 
 
3.2 Platinum black electroplated micro impedance sensors 
Theoretically, electrodes with high effective surface areas are ideal to overcome 
the problem with double-layer impedance.  Platinum black electroplated electrodes have 
porous surface structures, thus increasing the effective electrode surface area.  This can 
reduce the electrode surface double-layer impedance by two orders of magnitude [17, 18].  
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Consequently the channel resistance becomes the dominant system impedance in some 
intermediate frequency range, and the device becomes sensitive to what is flowing inside.  
Platinum black electroplated micro electrodes have been used for extracellular neural 
signal recording [11−13], gas sensing [14], and thermal infrared detection [15]. Reported 
here is the use of platinum black electroplated microelectrodes as AC impedance sensors 
for human blood cell count. 
In the following subsections of 3.2, the system model and two special cases are 
first presented.  Then the design and fabrication of two types of devices follow.  The 
principle of electrical impedance sensing with platinum black electroplated devices was 
validated with impedance spectra measurements first and then with flow sensing of 
polystyrene beads.  Finally, the results of flow sensing of human blood cells in diluted 
whole blood and leukocyte-rich plasma (LRP) are presented. 
3.2.1 Principle and model 
The platinum black electroplated impedance sensor can be modeled equivalently 
as the channel impedance, Z, in series with a constant phase element (CPE) and in 
parallel with the stray capacitance, Cst, as shown in Fig. 3-5.  Z includes electrolyte 
impedance and the impedance of the particle to be sensed between the electrodes.  The 
particle was sensed at 10 kHz.  In this low-frequency regime, the resistance component of 
the channel impedance dominates the reactance component.  Therefore, the channel 
impedance is effectively modeled as a resistor R.  A CPE is contributed by the electrode 
double-layer impedance of the electrolyte-electrode interface.  It can include the effects 
of double-layer capacitance, inhomogeneous reaction rates, charge transfer on electrode 
surface, and transport of electrochemical active components from and to the surface.  It is 
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affected by factors such as surface roughness, types of ions, ionic concentrations, 
temperature, and electrode potential.  Cst is the coupling capacitance between the two 
electrodes. 
 
 
Figure 3-5 System Model of platinum black electroplated impedance sensor 
 
The double-layer impedance due to the electrode-electrolyte interface is 
capacitive in nature.  But nonideal factors, i.e., inhomogeneity and dispersion of the 
system, makes it more practical to model the double-layer impedance as a CPE.  
Impedance of CPE is:  
( )
0
CFE
ZZ
j αω= ,  (0 ≤ α ≤ 1),    (3.3) 
with constant Z0, 1j = − , angular frequency ω, and exponent α between zero and one.  
The phase of the CPE is a constant of -απ/2.  Normal metal electrodes have α close to 
one and the CPE behaves like a capacitor with phase of -π/2, in which case Z0 is 
simplified to the inverse of the double-layer capacitance Cdl.  There are at least two 
effects that can make α deviate from one.  The surface roughness can change α from 1 in 
perfect flat two-dimensional electrodes, to 0.5 in three-dimension porous cubic electrodes 
[19].  Another effect that is likely to change α in the microdomain is the difference 
between the electrochemically active ionic concentrations on electrode surfaces and the 
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bulk ionic concentrations.  In microdevices, the ratio of electrode surface area to the 
volume of the sensing zone is so large that the electrochemical reaction on the electrode 
surface can be diffusion limited.  Also the small size of the channel sets up a diffusion 
barrier for active ions. 
From the system model, the overall measured impedance can be written as:  
0
1
1
( )
system
st
Z
j C ZR j α
ω
ω
=
+
+
.   (3.4) 
Ideally when the particle is present at the sensing zone, its impedance will dominate the 
channel impedance and the overall measured impedance.  This requires: 
0 1
( ) st
Z R
j j Cαω ω≤ ≤ ,   (3.5) 
which translates into the requirement: 
1
1 1
0stR C Z
α
α α− −≥ .   (3.6) 
Clearly from equation (3.6), lowering the stray capacitance and double-layer 
impedance are favored for particle sensing.  If the channel impedance satisfies equation 
(3.4), the system shows some typical asymptotic behaviors. When ω approaches zero, the 
system is reduced, approximately, to the channel impedance in series with the CPE.  
When ω approaches infinity, the system approaches the channel impedance in parallel 
with the stray capacitance.  These asymptotic behaviors are illustrated in the Nyquist plot 
of Fig. 3-6, which can be used to extract parameters for measurement. 
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Figure 3-6 Asymptotic behaviors of platinum black electroplated impedance sensors in 
Nyquist plot.  ω0 is the angular frequency when ZRe is R/2. 
 
In order for the system to sense particles flowing past the electrode, the particle 
impedance should be the major component in overall system impedance at the excitation 
frequency.  This is difficult to achieve in microsystems because of the miniaturization of 
the electrodes.  In the low-frequency range, impedance of the CPE dominates the system 
impedance, while at high frequency the stray capacitance dominates.  For particle sensing 
in low-frequency domain, an effective way is to lower impedance of the CPE by platinum 
black electroplating.  It can change the surface roughness of metal electrodes by making 
the surface extremely porous and increasing surface area by two orders of magnitude, 
thus reducing electrical impedance by two orders of magnitude. 
There are two special cases which will be considered:  1) α is close to one, and 2) 
α is close to 0.5.  For these two cases, it is possible to gain some physical intuition from 
the equivalent model. 
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When α approaches one, the CPE effectively becomes a double-layer capacitance 
Cdl.  To be more general, we also include a resistor Rct in parallel with Cdl for charge 
transfer resistance.  The system equivalent model is simplified as the inset of Fig. 3-7.  
The system impedance has two poles (P1 and P2) and one zero (Z1) which can be 
expressed as: 
1
1 2
1
( ) ( )
(1 )(1 )sys ct
s
ZZ s R R s s
P P
+
= + + +  . (3.7) 
For microelectrodes, Rct (~ GΩ) is much larger than R (< 100 kΩ).  Therefore, 
1
1
dl
Z
RC
= ,    (3.8) 
1
dl st
dl st
C CP
RC C
+= ,   (3.9) 
2
1
( )ct dl st
P
R C C
= + .   (3.10) 
It can be shown that 2 1 1P Z P< <  under the condition R << Rct. 
For typical platinum black electroplated electrodes, the Bode plot of the 
magnitude of the system impedance in equation (3.7) contains a plateau frequency region 
limited by Z1 and P1.  The plateau frequency region defines the sensing zone, in which the 
overall impedance is sensitive to channel resistance. For frequencies lower than Z1, the 
system behaves as the double-layer capacitor Cdl.  For frequencies higher than P1, the 
stray capacitance Cst dominates the frequency response. 
Shown in Fig. 3-7 are two extreme cases where the sensing zone shrinks and the 
whole system behaves like a capacitor.  The first case is when R is extremely large.  This 
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is the case where the channel is filled with air or DI water instead of electrolyte.  The 
other case is with the electrodes without platinum black electroplating, which have a Cdl 
two orders of magnitude smaller.  Thus, the overall impedance is dominated by the 
double-layer impedance.  The signal due to the passing particles is reduced.  This effect is 
seen on the impedance spectra when zero Z1 moves to higher frequency and approaches 
the high-frequency pole P1.  One possible solution is to reduce the stray capacitance Cst.  
This will increase P1, shifting the sensing zone to higher operating frequency. This, 
however, is not always favorable.  It can make the device structure and sensing circuitry 
more complicated.  Another solution is to increase double-layer capacitance Cdl, which 
will decrease the zero frequency Z1 and extend the sensing zone to lower operating 
frequency. 
The other special case is when α is close to 0.5.  If this is the case, the slope of the 
low-frequency linear part on the Nyquist plot will be one.  This low-frequency region 
represents typical Warburg impedance, which generally indicates a diffusion-limited 
regime [20].  It will be shown later in this chapter that one type of the devices fabricated 
belongs to this case. 
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Figure 3-7 Bode plot of numerical simulation of impedance magnitude spectra of 
platinum black electroplated impedance sensor device I.  Inset is the simplified circuit 
diagram.  Dash lines are asymptotes 
 
 
Figure 3-8 Bode plot of numerical simulation of impedance phase spectra of platinum 
black electroplated impedance sensor device I. 
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3.2.2 Device design and layout 
Fig. 3-9 shows an overview of device I.  There are three devices on each chip.  
The middle one has an aperture size of 20 μm in length by 15 μm in width.  It has two 
pairs of electrodes separated by 50 μm.  Channel height is 20μm and channel wall 
thickness is 10 μm.  All tests were performed using the middle device. 
 
 
Figure 3-9 Fabricated platinum black electroplated impedance sensor device I 
 
The chip layout for device II is illustrated in Fig. 3-10.  Two fluidic chambers are 
separated by an aperture.  The width of the aperture is 15 μm.  The length of the aperture 
is 30 μm.  One pair of metal electrodes is used to sense the electrical impedance across 
the aperture.  The size of the chamber is very large compared with the aperture so that the 
measured channel impedance is dominated by the impedance of the aperture region.  The 
distance between the electrodes is 70 μm.  At the inlet and outlet, some filter structures 
are designed to mechanically block contaminants and particle aggregates and prevent 
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them from clogging the aperture.  Channel height is optimized to be around 15 μm so that 
all blood cells can pass while maintaining the maximum signal magnitude. 
 
 
Figure 3-10 Design layout of platinum black electroplated impedance sensor device II 
 
3.2.3 Device fabrication 
Device I is based on integrated parylene technology (Fig. 3-11) [21].  The benefits 
of parylene include its processibility, stability, flexibility, and biocompatibility.  The 
parylene channels are strengthened by SU8.  The process is started with thermal growth 
of oxide to provide electrical isolation.  Then Ti/Pt/Ti (200A/2000A/200A) electrodes are 
patterned by liftoff process.  The top layer of Ti inside the channels is etched away with 
buffered HF.  Ti/Pt electrodes are used because they are chemically inert and can 
withstand high voltage without erosion for the duration of the device’s use.  Other 
portions of the top Ti layer are kept to provide superior adhesion to parylene. To avoid 
parylene channel delamination during later processing stages, parylene anchors are made 
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on silicon using DRIE.  Then 10 μm of parylene is deposited by CVD and patterned by 
RIE with an Ti/Au mask.  Before sacrificial photoresist releasing in acetone, a 50 μm 
thick SU8 layer is coated and patterned to planarize the surface and strengthen the 
parylene channels.  Finally, platinum black is electroplated selectively on electrode 
surfaces that are exposed to electrolyte.  Electroplating solution was introduced into the 
channel either by syringe injection or vacuum suction. 
 
 
Figure 3-11 Fabrication process flow for platinum black electroplated impedance sensor 
device I 
 
A transparent acrylic packaging jig was designed and fabricated for device I to 
provide convenient electrical and fluidic accessibility from the top and thus avoid 
backside wafer processing (Fig. 3-12).  The jig provides eight fluidic accesses 
simultaneously.  Commercial fittings (Upchurch Scientific, WA, USA) are used to 
connect between the jig and other fluidic components, such as syringe pumps or outlet 
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tubings.  There is a recess at the bottom of the acrylic jig which provides space for an 
epoxy-strengthened wire bond region on the chip. 
After fabrication, the chip is glued and wire bonded onto a printed circuit board 
(PCB). There are a total of 44 pads on the PCB of which only 12 are used.  A 200 μm 
thick PDMS layer with through holes is aligned and placed on top of the chip to provide 
sealing between the jig and the chip.  Finally, the jig is tightened firmly onto the PCB 
with screws (Fig. 3-13). 
The fabrication of device II is based on soft lithography [22].  It starts with 
molding channel structure on PDMS with a DRIE etched Si mold.  Ti/Pt (200 A/2500 A) 
electrodes are patterned on a soda-lime glass substrate by E-beam evaporation and lift-off 
process.  Platinum black is then electroplated on the areas where metal electrodes are 
exposed to electrolyte.  The thickness of the electroplated platinum black layers is 
normally greater than 1 μm.  Finally, the PDMS block is bonded to the glass surface at 80 
℃ overnight.  After fabrication, the chip is glued and wire bonded onto a printed circuit 
board. 
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Figure 3-12 Chip assembly with jig and PCB for platinum black electroplated impedance 
sensor device I 
 
 
Figure 3-13 Assembled platinum black electroplated impedance sensor device I with jig 
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3.2.4 Testing materials and setup 
5 μm, 8 μm, and 10 μm polystyrene beads were purchased from Duke Scientific 
Corporations, Fremont, CA.  Fresh human blood was obtained from healthy donors and 
used within three days.  EDTA was added to the blood collection tube to prevent 
coagulation.  Blood samples were diluted in phosphate buffered saline (10x PBS Ambion, 
Austin, TX).  The impedance spectra of the device filled with different media were 
measured with an LF impedance analyzer (HP 4192A, Santa Clara, CA).  The excitation 
voltage was set to 0.1 V for all measurements.  For flow sensing, the particles were 
introduced into devices by a syringe pump (Harvard Apparatus Pico Plus, Holliston, MA).  
Electrical excitation and particle pulse sensing were performed with a lock-in amplifier 
(EG&G Princeton Applied Research 5210, Princeton, NJ). 
3.2.5 Platinum black electroplating 
Platinum black was electroplated selectively on the electrode surface exposed in 
the channel.  Electroplating solution contains 1% chloroplatinic acid (Sigma C-3044), 
0.0025% hydrochloric acid, and 0.01% lead acetate in water [17].  Electrodes were plated 
with 5 V DC through a 10 MΩ resistor for up to four minutes. 
To preventing the platinum black from being exposed to potentially destructive 
chemicals during device fabrication, the platinum black electroplating is performed as the 
last step after channel release.  Electroplating solution is introduced into the channels.  
The electroplating process for device I is not as easy to control as that of device II, which 
is performed in a reservoir of electroplating solution.  As a result, the electroplating for 
device I is not as complete as that of device II.  This is an important factor in explaining 
the differences in impedance spectra of the electrodes from the two processes. 
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SEM pictures of a platinum black electroplated electrode of device I and II are 
shown in Fig. 3-14.  The surface of device II is much rougher than device I, which 
suggests a more complete platinum black electroplating. 
 
 
Figure 3-14 SEM pictures of platinum black electroplated electrodes.  (A) device type I. 
(B) device type II 
 
Fig. 3-15 shows images from AFM measurements of platinum electrodes before 
and after Pt black electroplating.  The surface feature size becomes much larger after Pt 
black electroplating.  The measured surface roughness changed from 6.75 nm to 238 nm, 
an increase of 35 times. 
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Figure 3-15 AFM images of platinum electrode before electroplating (A) and after 
electroplating (B) of device II.  Note the scales are different, with maximum of 40 nm in 
(A) and 1.5 μm in (B). 
 
3.2.6 Impedance spectra measurement 
Measured impedance spectra of device I are shown in Fig. 3-16 and Fig. 3-17, 
which demonstrate the introduction and expansion of the sensing frequency zone by 
platinum black electroplating.  The frequency responses of air and water almost overlap.  
Their magnitude responses are straight lines and phase responses kept a constant -90 
degree angle for the frequency range scanned.  This agrees with the case of large R in the 
model analysis.   
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Figure 3-16 Bode plot of measured impedance magnitude response in different 
environments of platinum black electroplated impedance sensor I. Electroplating with 
platinum black (the lower two curves) effectively expand the sensing zone. 
 
Figure 3-17 Bode plot of measured impedance phase response of platinum black 
electroplated impedance sensor I 
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Before platinum black electroplating, both phosphate buffered saline (PBS) and 
high salt solution (7.2% sodium chloride) have little impact on the frequency response.  
This is because at high frequency, the system is dominated by stray capacitance, Cst, and 
at low frequency by Cdl.  Since Z1 and P1 are so close, the sensing zone in the frequency 
domain shrinks to zero.  After electroplating, Cdl was measured to be 2.5 nF, an increase 
of two orders of magnitude.  The magnitude response showed a plateau region between 1 
kHz and 30 kHz.  This region expanded as the time of electroplating increased.  The 
expansion is caused mainly by reducing the low-frequency bound, which is determined 
by the double-layer impedance.  The high-frequency bound remains almost unchanged.  
The high frequency is determined by the large stray capacitance, which is mainly caused 
by the coupling between the electrodes and the Si substrate.  It can be improved by using 
a thicker oxide insulation layer or building devices on electrical insulating materials, such 
as glass.  The phase response exhibits a large increase in the sensing zone and the 
maximal phase of -20 degrees at 5 kHz is achieved for four minutes of platinum black 
electroplating.  Fig. 3-18 is the Nyquist plot with a linear fit on the low-frequency part 
and circular fit on the high-frequency part. 
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Figure 3-18 Nyquist plot of platinum black electroplated impedance sensor device I.  
Dash lines are fitted curves. 
 
Fig. 3-19 shows the Bode plot of measured and simulated impedance magnitude 
and phase responses of device II.  Similar to device I, before platinum black 
electroplating, the system impedance response shows capacitive characteristics in all 
frequency ranges.  And the impedance responses in air, deionized (DI) water, and PBS 
are similar to device I (data not shown here).  After platinum black electroplating, 
resistive characteristics in the frequency range from 100 Hz to 3 MHz (the plateau in the 
figure) appear.  This is the frequency range suitable for cell sensing.  α = 0.5 is used to fit 
the impedance spectra measurement data to the model proposed as before.  Table 3-1 lists 
parameters extracted from the Nyquist plots (Fig. 3-18 and Fig. 3-20) of the asymptotic 
behaviors of device I and II. 
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Comparing system impedance spectra of device I and device II, device II has a 
broader sensing zone (100 Hz−3 MHz versus 1 kHz−30 kHz).  The glass substrate of 
device II has a lower stray capacitance than the oxide-isolated Si substrate of device I.  
This extends the high bound of the sensing zone by one decade.  The improvement in the 
lower bound of the sensing zone was mainly due to the platinum electroplating.  From the 
SEM pictures of Fig. 3-14, the platinum black electroplating is more complete for device 
II.  Consequently, the electrode surface of device II is rougher and resembles more of a 
3D structure.  This is reflected in the measured α values of the two types of devices.  The 
difference of α values between device I and device II is likely caused by the difference in 
surface roughness of these two types of devices. 
 
Figure 3-19 Bode plot of simulated and measured system impedance magnitude (solid 
lines) and phase (dash lines) response in electrolyte phosphate buffered saline (PBS) of 
platinum black electroplated impedance sensor device II.  Data were fitted by least-
squares curve-fitting, with parameters Z0 = 2.24 MΩ, Cst = 0.5 pF, and α=0.5. 
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Figure 3-20 Nyquist plot of measured impedance data of platinum black electroplated 
impedance sensor device II 
 
Table 3-1  Parameters obtained by fitting Nyquist plots to asymptotes of platinum black 
electroplated impedance sensor device II.  Low-frequency domain was fitted to a straight 
line and high-frequency data were fitted to a part of circular curve. R2 is the multiple 
correlation coefficient. 
 Device I Device II 
A (kΩ) -161.1 ± 1.3 -35.22 ± 0.25 
B 7.304 ± 0.047 1.074 ± 0.006 
Linear 
–ZIm=A+BZRe 
R2 0.9992 0.9986 
a (kΩ) 12.62 ± 0.05 16.9 ± 0.2 
b (Ω) -326 ± 8 -281 ± 197 
r (kΩ) 13.0 ± 0.8 17.9 ± 0.2 
Circular 
(ZRe-a)2+(–ZIm-b)2=r2 
R2 0.9989 0.9967 
R (kΩ) 26.0 35.8 
Cst (F) 1.3 n 3.6 p 
α 0.91 0.52 
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3.2.7 Flow sensing of polystyrene beads 
Results of bead and human blood cell sensing are presented here only for device II.  
Similar results were obtained for device I.  Polystyrene beads with different sizes were 
used to calibrate the system.  The flow rate was 1 nL/min.  The particle concentrations 
were in the range of 104 beads/μL.  Fig. 3-21 shows an example of a time trace of 8 μm 
polystyrene beads.  The peak height was 0.2608 V ± 0.0127 V less than a 5% standard 
deviation, for a sample of 43 beads in one testing.  The duration of the peaks were 17.21 
ms ± 0.67 ms, which corresponded well with the expected time for the beads to pass the 
sensing zone.  Fig. 3-22 is a typical peak from the same data set.  Measured signals from 
5 μm and 10 μm polystyrene beads are plotted in Fig. 3-23.  Theoretical channel 
resistance change with DC excitation was calculated and plotted as the dashed line.  It is 
well known as the Coulter principle, that under DC excitation the signal magnitude is 
determined by the volume of the particles.  Our measurement results confirmed that for 
low excitation frequency, such as 10 kHz, the magnitude of resistance change was 
determined by the particle size. 
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Figure 3-21 Time trace of 8 μm beads tested at 10 kHz in platinum black electroplated 
impedance sensor device II.  Detected peaks are labeled. 
 
 
Figure 3-22 A typical example peak of 8 μm beads tested at 10 kHz in platinum black 
electroplated impedance sensor device II.  The solid line is least-squares curve-fitting to 
a parabola 
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Figure 3-23 Sensing signal depends on the size of polystyrene beads in platinum black 
electroplated impedance sensor device II.  Dash line is theoretical relationship at DC. 
 
3.2.8 Flow sensing of human blood cells 
Human blood cell sensing was performed either with diluted whole blood or 
diluted leukocyte-rich plasma.  Whole blood samples were obtained from healthy donors 
and used within 48 hours.  Normal whole blood has an erythrocyte-to-leukocyte ratio of 
about one thousand to one.  Hence, it is suitable for erythrocyte characterization without 
leukocyte interference.  Leukocyte-rich plasma was prepared by collecting the plasma 
fraction after whole blood sedimentation in Wintrobe tubes.  Erythrocyte-to-leukocyte 
ratio can be reduced by at least two orders of magnitude.  Therefore, leukocyte-rich 
plasma is better for leukocyte testing.   
Fig. 3-24 shows a time trace for human whole blood diluted one thousand times 
with PBS and Ficoll-Paque Plus.  The signal-to-noise ratio is not as good as for the 8 μm 
beads, and a slowly drifting baseline was sometimes experienced.  Closeups of peaks are 
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shown in Fig. 3-25.  The peak height has a wide distribution, which indicates that the cell 
size varied.  The distribution of pulse height matches well with the known volume 
distribution of erythrocytes (Fig. 3-26).  Leukocyte-rich plasma was used for leukocyte 
sensing.  The tail part of the peak height distribution is due to leukocytes.  The data 
resembles the known leukocyte volume distribution (Fig. 3-27). 
 
 
Figure 3-24 Time trace of diluted human whole blood in platinum black electroplated 
impedance sensor device II.  Detected peaks are labeled 
 
 
Figure 3-25 Sensing cells from diluted human whole blood in platinum black 
electroplated impedance sensor device II.  The solid lines are least-squares curve-fittings 
to parabola: (A) a typical peak, (B) two close peaks, (C) two peaks too close to be 
separated. 
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Figure 3-26 Pulse height distribution of diluted human whole blood, in which leukocyte 
to erythrocyte ratio is about one to a thousand.  Inset is erythrocyte volume distribution 
from [23]. 
 
Figure 3-27 Pulse height distribution of leukocyte rich plasma, in which leukocyte to 
erythrocyte ratio is about one to ten. Middle inset shows the detail of the tail of the 
distribution.  Top inset is leukocyte volume distribution from [23]. 
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3.3 Inductor-induced resonance impedance sensing 
In traditional AC impedance sensing, the electrodes are a metal helical conduit, in 
which the particle suspension flows.  The metal conduit acts as an electrical inductor.  To 
achieve electrical isolation, an external parallel capacitor is introduced to induce 
resonance and make the metal conduit a high-impedance path for the electrical signal.  
Alternatively, an external parallel inductor can be introduced into the system for the 
purposes of AC impedance sensing.  At the resonant frequency, the capacitive 
components of the system are nullified by the inductor, leaving the channel impedance to 
be the major component in system impedance.  Unlike the traditional AC impedance 
sensor system, the inductor is introduced to nullify the inherent capacitive components.  
We recently demonstrated that the sensitivity of a microchip capacitively-coupled 
contactless conductivity detector (C4D) can be improved by more than 10,000 times [24].  
In this study, conventional discrete coil inductors were used to demonstrate the principle, 
but the inductors can also be fabricated on the microchip to provide an integrated solution 
[25]. 
3.3.1 Principle 
The device without the inductor connected can be modeled as the channel 
impedance, Z, in series with a double layer capacitance, Cdl,, in parallel with the stray 
capacitance Cst as in Fig. 3-28.  Z includes electrolyte impedance and impedance of 
particle to be sensed between the electrodes.  For low-frequency excitation (under 100 
kHz), the resistance part of the channel impedance dominates the reactance part.  So in 
the following, the channel impedance is effectively modeled as a resistor, R.  Cdl is due to 
the electrolyte-electrode interface.  For micro metal electrodes without surface treatment, 
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this is a reasonably good approximation.  Cst is the coupling capacitance between the two 
electrodes.  After an inductor is connected to the system, its inductance (L) and resistance 
(RL) are included in the model. 
 
 
Figure 3-28 System model of inductor-induced resonance impedance sensor.  The 
channel impedance Z is replaced with channel resistance R in later analysis. 
 
From the system model, the overall measured impedance can be written as:  
1( ) 1 1
1
sys
st
L
dl
Z j
j C
R j LR j C
ω
ω ωω
=
+ + ++
.   (3.11) 
When the total current and the terminal voltage is in phase, the parallel circuit is 
considered to be in resonance[26].  In resonance, the imaginary part of the total 
admittance (the susceptance) will be zero, from which the resonant frequency and the 
impedance (resistance) at resonance can be calculated as: 
2
0 2 2 2 2
1
2 2 2
L
dl st
Rf
L C C L Rπ
Δ= − + ,    (3.12) 
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2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 24 ( ) ( )dl st d l d l s t d l L s t L dl s t d l d l s t LC L C L C L R C C L R L C R C R C L C L C L R C C R RΔ = − − + + − − + + + + − +
.         (3.14) 
Under conditions, 2st LL C R>> , the above equations can be simplified: 
2 22simple dlC LRΔ ≈ ,    (3.15) 
0,
1 1
2simple st
f
C Lπ= ,   (3.16) 
2
1
0, 2 2( )
st L dl
simple
dl st
C R C RZ
L C R C L
−= + + .  (3.17) 
3.3.2 Devices design and layout 
Two types of devices were designed and fabricated.  Device I is designed for 
sensing at a single frequency.  Device II is designed for sensing at dual frequencies.  The 
chip layout for device I is illustrated in Fig. 3-29.  Two parallel sensing zones double the 
system throughput and enable differential input to sensing circuitry to reduce drift and 
noise.  The two fluidic chambers are separated by an aperture.  The width of the aperture 
is 14 μm.  The length of the aperture is 20 μm.  One pair of metal electrodes is used to 
sense the electrical impedance across the aperture.  The size of the chamber is very large 
compared with the aperture, so the measured channel impedance is dominated by the 
impedance of the aperture region.  The distance between the electrodes is 50 μm.  At the 
inlet, filter structures are fabricated to mechanically block contaminants and particle 
aggregates and prevent clogging of the aperture.  Channel height is optimized to be 
around 15 μm to allow blood cells to pass while maximizing signal magnitude. 
For device II, two pair of electrodes for sensing, at low and high frequency 
respectively, are separated by 100 μm (Fig. 3-30).  These electrodes also measure the 
real-time particle velocity inside the channel. 
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Figure 3-29 Design layout of inductor-induced resonance impedance sensor device I 
 
Figure 3-30 Device design and fabricated device of inductor-induced resonance 
impedance sensor device II.  (A) Fluidic passage including inlet/outlet, filter and channel 
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and with electrodes patterned on bottom.  (B) Assembled device.  (C) Closeup view of 
the sensing region.  (D) Close-up view of the filter region. 
 
3.3.3 Device fabrication 
The fabrication of the device is based on soft lithography [22].  It was started with 
molding channel structure on PDMS with a DRIE-etched Si mold.  Ti/Pt (200 A/2500 A) 
electrodes are patterned on a soda-lime glass substrate with E-beam evaporation and lift-
off process.  Finally the PDMS block is bonded to a glass surface at 80℃ overnight.  
After fabrication, the chip is glued and wire bonded onto a printed circuit board. 
3.3.4 Testing materials and setup 
5 μm polystyrene beads were purchased from Duke Scientific Corporation, 
Fremont, CA.  Fresh human blood was obtained from healthy donors and used within 
three days.  EDTA was added to the blood collection tube to prevent coagulation.  Blood 
samples were diluted in phosphate buffered saline (10x PBS Ambion , Austin, TX).  The 
impedance spectra of the device filled with different media were measured with an LF 
impedance analyzer (HP 4192A, Santa Clara, CA).  The excitation voltage was set to 0.1 
V for all the measurements.  Before particle flow testing, the resonant frequency of the 
system with the parallel inductor connected was identified from the impedance spectra 
measurement. 
During flow sensing with device I, the particles were introduced into devices by a 
syringe pump (Harvard Apparatus Pico Plus, Holliston, MA).  Electrical excitation and 
particle pulse sensing were performed with a lock-in amplifier (EG&G Princeton Applied 
Research 5210, Princeton, NJ) on one of the electrode pairs across one aperture.  A 
voltage signal with constant amplitude was applied and the total current was measured.  
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Limited by the bandwidth of this lock-in amplifier, inductors with inductance value  
larger than 400 mH are needed in particle sensing to achieve resonant frequency under 
100 kHz. 
For device II testing, an inductor of 1 mH was connected in parallel to the device 
for sensing at 2.05 MHz, and inductors with a total of 1 H of inductance were used for 
sensing at 77 kHz.  Without the inductor connected, the differences among system 
impedance spectra in air, DI water, and electrolyte solution PBS were small, indicating 
the device has poor sensitivity.  Parallel inductors introduced resonance at specific 
frequencies determined by the inductance.  Lock-in amplifier EG&G 5210 was used in 
current sensing mode for the low-frequency (77 kHz) signal.  Another high-frequency 
lock-in amplifier SRS 844 (Stanford Research Systems, Sunnyvale, U.S.A.) was used in 
voltage sensing mode for the high-frequency (2.05 MHz) signal.  A transimpedance 
amplifier was built to convert the current signal to a voltage signal before it was applied 
to the input of the high-frequency lock-in amplifier. 
3.3.5 Impedance spectra measurement 
3.3.5.1 Impedance spectra measurement of device I 
Without the parallel inductor connected, the system impedance spectra were 
measured (Fig. 3-31).  The impedance magnitude responses are straight lines with slope 
of -1.  The impedance phase responses are constant at -90 degrees.  These results mean 
the system behaved effectively as a capacitor.  The impedance spectra had similar 
impedance responses whether the channel was filled with air, water or phosphate 
buffered saline (PBS).  This confirmed that for bare micro electrodes, the sensors are not 
sensitive to the change of channel resistance.  The system impedance spectra connected 
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with inductors of various inductance values were measured in PBS.  Each impedance 
spectrum curve had one resonant frequency, at which the impedance magnitude achieved 
its maximum.  Around this resonant frequency, the phase of the impedance changes from 
+90 degrees to -90 degrees, indicating the system changes from inductance dominant to 
capacitance dominant.  The resonant frequency increases as the inductance value 
decreases. 
The measurement data were fitted with the model.  The inductance and resistance 
of various inductors were measured separately.  The fitting was performed iteratively.  
The initial trial value of stray capacitance was approximated from the impedance spectra 
measurement in PBS without any parallel inductor.  The initial channel impedance with 
PBS was approximated by calculation of DC resistance given the channel geometry and 
the conductivity of PBS (1.6 S/m).  Fig. 3-32 is the simulated impedance spectra with Cst 
= 1 pF, Cdl  = 0.34 pF, and R = 50 kΩ for a system without inductors, and with Cst  = 5 pF, 
Cdl  = 1.7 pF, and R = 50 kΩ for a system with inductors.  The inclusion of inductors on 
the printed circuit board introduces extra stray capacitance which increases Cst.  Both the 
impedance magnitude and phase responses matched well with experimental data.  Table 
3-2 summarizes the measured and calculated resonant frequencies.  f0,meas  is the measured 
resonant frequency.  f0,num is the frequency to achieve the largest impedance magnitude in 
numerical simulation.  f0,cal is calculated using equation (3.12) with the definition of 
resonance.  f0,cal_simple is calculated from formula (3.16). 
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Figure 3-31 Bode plots of measured system impedance responses in different 
environments and with various inductance values of inductor-induced resonance 
impedance sensor device I.  The solid lines are impedance magnitude responses.  The 
dash lines are impedance phase responses. 
 
Figure 3-32 Bode plot of simulated impedance response with various inductance values 
of inductor-induced resonance impedance sensor device I.  The solid lines are impedance 
magnitude responses.  The dash lines are impedance phase responses.  
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Table 3-2 Calculation and measurements of resonance frequency for four cases of 
different parallel inductors 
L (mH) RL (Ω) f0,meas (MHz) f0,num (MHz) f0,cal (MHz) f0,cal_simple (MHz) 
0.1 5.12 6.4 7.08 7.04 7.12 
1 22 2.0 2.09 2.10 2.25 
10 73 0.71 0.617 0.623 0.712 
100 184 0.18 0.195 0.195 0.225 
 
f0,num and f0,cal are almost identical; hence, when the system is in resonance, its 
impedance magnitude is maximized.  Both f0,num and f0,cal are very close to f0,meas, with 
maximal difference of approximately 10% for all four cases of different inductance 
values.  The simple formula of (3.16), which was based on the assumption that the 
resonance was established mainly by the inductor and the stray capacitor, actually 
resulted in a very good approximation of the resonant frequency.  This indicates that for 
this device, the added parallel inductor mainly nullifies the stray capacitor at resonant 
frequency.  For conventional coil inductors used in testing, the inductance is proportional 
to the square of the number of coil turns, while the inductor resistance is proportional to 
the number of coil turns [24].  So the relationship of RL and L can be fitted using the 
formula: 
LR k L=  .  (3.18) 
From Table I, k was fitted to be 18.3 ± 1.6 Ω/mH1/2.  By plugging equation (3.18) 
into equation (3.12), the relationship between resonant frequency and inductance can be 
obtained.  This relationship and the results from the simple resonant frequency 
approximation are plotted in Fig. 3-33A.  The two curves almost overlap, especially in 
the low-inductance (high-resonant-frequency) region.  The difference at high inductance 
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of 1 H is only approximately 16%.  So for this device, equation (3.16) can be used to 
estimate the resonant frequency. 
With the approximation equations (3.16) and (3.18) for f0 and RL, the relationship 
between Z0 and f0 is determined: 
3
2
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1 12 1[1 ]
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For the device under investigation, the first range is below 10-9 Hz, the second is 
between 10-9 Hz and 1.6 MHz, the third is between 1.6 MHz and 5.7 GHz, and the fourth 
range is above 5.7 GHz.  So the relevant frequency range in our measurement is in the 
upper second range and lower third range.  Fig. 3-34B plots the impedance magnitude at 
resonance frequency (Z0) versus resonance frequency (f0).  Measurement points 
corresponding to the peak positions in Fig. 3-31 are labeled. 
 
   
 
 
120
 
Figure 3-33 Simulation and measurements for (A) resonance frequency and (B) 
impedance magnitude at resonance frequency of inductor-induced resonance impedance 
sensor device I.  The red lines are calculation using formulas (2) and (3), which are 
directly derived from model.  The blue lines are calculation with simplification using 
equations (6), (7), and (8).  The black dots are measured points with extrapolation. 
 
3.3.5.2 Impedance spectra measurement of device II 
An example of measured impedance spectra of device II is shown in Fig. 3-34.  
Due to the limitation of the LF impedance analyzer, the upper limit of frequency sweep 
range is 13 MHz and the upper limit of impedance magnitude is 1.2 MΩ.  The 
measurement data were fitted with the model.  The fitting was performed iteratively.  The 
initial trial value of stray capacitance was approximated from the impedance spectra 
measurement in PBS without any parallel inductor.  The initial channel impedance with 
PBS was approximated by calculation of DC resistance, given the channel geometry and 
the conductivity of PBS (1.6 S/m).  Fig. 3-35 is the simulated impedance spectra with Cst 
= 5 pF, Cdl  = 4 pF, and R = 40 kΩ for a system without inductors and with Cst  = 1 pF, Cdl 
(A) 
 
(B)
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= 0.5 pF, and R = 40 kΩ for a system connected with inductors.  The inclusion of 
inductors on the printed circuit board introduces extra stray capacitance which increases 
Cst.   
 
 
Figure 3-34 Measured impedance magnitude (left axis and solid lines) and phase (right 
axis and dotted lines) spectra of inductor-induced resonance impedance sensor device II 
without inductor connected and filled with air, DI water, and electrolyte PBS, as well as 
device in PBS with inductors of various values connected. 
 
Similar to device I, the relationship between resonance frequency and inductance, 
as well as the relationship between the impedance magnitude at resonance frequency and 
the resonance frequency, are plotted in Fig. 3-36 for device II.  The simplification is 
justified and the model fits the measurements. 
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Figure 3-35 Simulated impedance magnitude (left axis and solid lines) and phase (right 
axis and dotted lines) spectra of inductor-induced resonance impedance sensor device II 
without inductor and with inductors of various values connected.  Boxed range 
corresponds to the whole plot range in Fig. 3-34. 
 
 
(A)
 
(B)
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Figure 3-36 Simulation and measurements for (A) resonance frequency and (B) 
impedance magnitude at resonance frequency of inductor-induced resonance impedance 
sensor device II.  The red lines are calculation using formulas (2) and (3), which are 
directly derived from model.  The blue lines are calculation with simplification using 
equations (6), (7), and (8).  The black dots are measurement with extrapolation. 
 
3.3.6 Study on the sensitivity 
The sensitivity of the measurement system to a parameter α is defined as: 
1 sys
sys
Z
S
Zα α
∂= ∂   .  (3.21) 
From the above definition, we calculated the sensitivity to R, SR, and to Cdl, SCdl.   
SR is a figure of merit for the system performance.  Higher SR indicates better 
system performance.  Cdl can change with environment during measurement.  SCdl is a 
measurement of system resistance to Cdl change during measurement.  Lower SCdl 
indicates higher system performance.  SR versus frequency for five cases of various 
inductance values and for the case of no inductor are plotted in Fig. 3-37A for device I 
and in Fig. 3-38B for device II.  All cases with an inductor connected have a single peak 
at the corresponding resonant frequency, while the case without a parallel inductor has a 
very broad peak.  The peaks of SR for all five cases of parallel inductors are one order of 
magnitude higher than the case without the parallel inductor, with the exception of the 1 
mH inductance.   
 
   
 
 
124
 
Figure 3-37 Sensitivity study on inductor-induced resonance impedance sensor of device 
I.  (A) The sensitivity to R for various parallel inductors and no inductor connected in 
device I.  The curve without inductor overlaps with the high-frequency regions of the 10 
mH and 100 mH cases.  (B) The sensitivity to Cdl for various parallel inductors and no 
inductor connected.  (C) Sensitivity improvement for R and Cdl.  (D) Ratio of SR and SCdl 
versus frequency with and without inductors. 
(C) (D) 
 
(A) (B) 
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Figure 3-38 Sensitivity study on inductor-induced resonance impedance sensor of device 
II. (A) The sensitivity to R for various parallel inductors and no inductor connected in 
device II.  The curve without inductor overlaps with the high-frequency regions of the 10 
mH and 100 mH cases.  (B) The sensitivity to Cdl for various parallel inductors and no 
inductor connected.  (C) Sensitivity improvement for R and Cdl.  (D) Ratio of SR and SCdl 
versus frequency with and without inductors. 
 
SCdl versus frequency for five cases of various inductance values and for the case 
without parallel inductor are plotted in Fig. 3-37B for device I and in Fig.3-38B for 
device II.  All the cases with inductor connected also have a dominating single peak at 
(A) (B)
(C) (D)
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the corresponding resonant frequency, while the case without parallel inductor has a 
plateau in the low-frequency region. 
It is interesting to note that there is a broad peak for the case without inductor 
connected and the peak centered on frequency 1
1
2 dl
f
C Rπ= .  In cases with a parallel 
inductor connected, if the resonant frequency f0 is lower than f1, the effect of Cdl still 
shows up in the capacitance-dominated frequency range (f > f0).  A similar broad peak 
appeared in sensitivity plots Fig. 3-37A and Fig. 3-38A.  On the other hand, if the 
resonant frequency f0 is higher than f1, this broad peak disappears because it is located in 
the inductance dominated frequency range (f < f0) and the effect is dominated by the 
inductor.  
Different from SR, the maximal SCdl for smaller inductance is much smaller than 
that for larger inductance, which indicates sensing at a resonant frequency of smaller 
parallel inductance will result in fewer errors caused by the change of double-layer 
capacitance during measurement. 
 
3.3.7 Flow sensing of polystyrene beads 
3.3.7.1 Flow sensing of polystyrene beads in Device I 
 Fig. 3-39A shows an example of time trace of 5 μm polystyrene beads.  The flow 
rate is 10nL/min.  The particle concentration is in the range of 104 beads/μL.  The peak 
height is 0.058 V ± 0.013 V for a sample of 249 beads.  The duration of the peaks is 37.8 
ms ± 6.8 ms, which corresponds well with the expected time that the beads passed the 
sensing zone.  Fig. 3.39B is a typical peak from the same data set. 
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Figure 3-39 Flow sensing of polystyrene beads in inductor-induced resonance 
impedance sensor device I (A) Time trace of 5 μm beads tested at resonant frequency of 
104 kHz.  Detected peaks are labeled.  (B) A typical example peak of 8 μm beads tested at 
104 kHz.  The solid line is least-squares curve-fitting to a parabola. 
 
3.3.7.2 Flow sensing of polystyrene beads in device II 
The devices are first validated with a mixture of 5 μm and 10 μm diameter 
polystyrene beads (Fig. 3-40).  A scatter plot of impedance at high frequency versus that 
at low frequency showed two separated regions. 
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Figure 3-40 Testing with 5 μm and 10 μm polystyrene beads mixture in 20 μm channel 
dimension in inductor-induced resonance impedance sensor device II. (A) Time trace of 
20 seconds.  (B) Closeup of an individual peak.  (C) Scatter plot of impedance 
magnitude.. 
 
3.3.8 Flow sensing of human blood cells 
Human blood cell sensing was performed either with diluted whole blood or 
diluted leukocyte-rich plasma.  Whole blood samples were obtained from healthy donors 
and used within 48 hours.  Whole blood was used for erythrocyte characterization and 
leukocyte-rich plasma was used for leukocyte testing.  
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3.3.8.1 Single-frequency sensing in Device I 
Fig. 3-41A shows a time trace for human whole blood diluted by one thousand 
times.  Close-ups of peaks are shown in Fig. 3-41(B)-(D). 
 
 
Figure 3-41 Time traces of flow sensing of human blood cells in inductor induced 
resonance impedance sensor device I.  (A): Time trace of diluted human whole blood 
tested at resonant frequency of 90.8 kHz.  Detected peaks are labeled.  (B)−(D): Sensing 
cells from diluted human whole blood.  The solid lines are least-squares curve-fittings to 
parabola: (B) a typical peak, (C) two close peaks, (D) two peaks too close to be 
separated. 
 
It is well known that under DC and low-frequency AC excitation, the change of 
channel impedance is correlated to the volume of the particles including biological cells.  
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The relationship between the channel resistance change and particle volume at DC [27, 
28] was used to calculate the change of total system impedance magnitude versus particle 
volume (Fig. 3-42).  Based on our proposed system model, and fitting parameters 
obtained from impedance spectra measurement, we calculated the total system impedance 
magnitude change when a particle in size ranging from 5 μm diameter to 14 μm diameter 
enters the aperture.  The data fits well onto a straight line.  Hence, the volume of the 
particles can be determined from the change of total impedance magnitude at resonance. 
 
 
Figure 3-42 Impedance magnitude change with the particle volume 
 
The peak height in Fig. 3-41 is approximately proportional to the change of total 
impedance magnitude. From Fig. 3-42, it is also approximately proportional to the 
particle volume.  So, the peak height distribution can be used to measure the particle 
volume distribution.  The peak height of blood cell traces (Fig. 3-41) had a wide 
distribution which indicates that the cell size varied.  The histogram of pulse height 
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matched well with the known volume distribution of erythrocytes (Fig. 3-43).  The tail 
part of the peak height histogram was contributed by leukocytes (Fig. 3-44), while the 
small pulse height portion (under 0.1 V) is presumably still dominated by erythrocytes.  
It resembles the known leukocyte volume distribution. 
 
Figure 3-43 Pulse height distribution of diluted human whole blood, in which leukocyte 
to erythrocyte ratio is about one to a thousand, in inductor-induced resonance impedance 
sensor device I.  Inset is erythrocyte volume distribution from [23]. 
 
Out of the 381 blood cell signals during the above testing with diluted whole 
blood, six coincident events like Fig. 3-41D were identified.  There were also two cases 
of close peaks as shown in Fig. 3-41C.  The coincident effect can be modeled as a 
Poisson process[29].  Cacluations using equation (3.2) results in a true count of 385.7.  
The difference between true count and observed count was 4.7, which is on the same 
order but a little less than the six coincident events observed.  This might reflect 
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statistical fluctuation, but it is more likely caused by the tendency to aggregation among 
blood cells.  
 
 
Figure 3-44 Pulse height distribution of leukocyte-rich plasma, in which leukocyte to 
erythrocyte ratio is about one to ten, in inductor-induced resonance impedance sensor 
device I.  Top inset is leukocyte volume distribution from [23]. 
 
3.3.8.2 Dual-frequency sensing in device II 
For human blood cell testing, two types of sample of blood cells were used.  
Diluted whole blood mainly shows the characteristic of the red blood cells (RBCs) 
because of the overwhelming number of RBCs over white blood cells (WBCs).  
Leukocyte rich plasma (LRP) was prepared with a WBC-to-RBC ratio on the order of 1:1.  
The difference between scatter plot of diluted blood and of LRP shows the characteristics 
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of WBCs (Fig. 3-45).  WBCs have higher impedance magnitude for both frequencies 
than RBCs, but the opacity (the slope of fitted straight line) is similar. 
 
 
Figure 3-45 Scatter plots of testing with 200 times diluted human whole blood (A) and 
1:1 diluted leukocyte-rich plasma (B) in 15 μm channel dimension inductor-induced 
resonance impedance sensor device I. 
 
3.3.8.3 Tumor cell differentiation using dual-frequency sensing 
Two epithelial tumor cell lines (breast adenocarcinoma MCF7, diameter 13.6 μm 
± 1.3 μm; urinary bladder carcinoma T24, diameter 16.43 μm ± 1.16 μm) were used as 
models of tumor cell characterization.  Both types of the tumor cells might be circulating 
tumor cells in the bloodstream.  Fig. 3-46 shows scatter plots of each cell line with and 
without added blood.  The diluted blood acted as an internal reference and also as a 
model system for detecting circulating tumor cells in blood.  Both cell lines have a range 
of impedance values, but the opacity keeps relatively constant.  Also they are distinctive 
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from blood cells, which can be the basis for detection and isolation of circulation tumor 
cells in the bloodstream. 
 
Figure 3-46 Scatter plots of testing with tumor cells spiked in diluted blood. (A) breast 
cancer cell line MCF7, (B) MCF7 mixed 1:1 with 1000 times diluted human whole blood, 
(C) bladder cancer cell line T24 and (D) T24 mixed 1:1 with 1000 times diluted human 
whole blood in 20 μm channel dimension devices. 
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The approach of inductor-induced resonance sensing can make the AC impedance 
particle sensing more flexible.  Inductors of different inductance values can be connected 
to different electrode pairs closely placed in the same channel.  In this way, the same 
particle can be probed at different resonant frequencies.  For biological cells, cellular 
structures inside the cell membrane have different characteristics in the RF range (the β
dispersion region).  This approach can be used for cell identification and characterization. 
 
3.4 Conclusions 
To solve the problem of large double-layer impedance of electrodes in micro 
impedance sensors, two methods were proposed and successfully verified.  One uses 
platinum black electroplating to increase the effective surface area of the electrode.  The 
other includes a parallel inductor in the system, and sensing at the resonance frequency 
greatly increases the sensitivity. 
For platinum black electroplated micro impedance sensors, two types of micro 
Coulter sensors were designed and fabricated for particle sensing in fluidic flow.  One 
was based on integrated parylene technology.  The other one was based on soft 
lithography.  A system model was developed to explain the measurement results, which 
included the channel impedance, the constant phase element, and the stray capacitance.  
Platinum black electroplating was performed on the electrode surface so that the sensing 
zone in the frequency domain could be identified.  The lower bound of the sensing zone 
was limited by the double-layer effect of the electrode-electrolyte interface.  The upper 
bound was limited by the stray capacitance.  The devices were calibrated with 
polystyrene beads of various diameters.  We confirmed that the signal magnitude was 
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determined mainly by the size of the particles at the testing frequency.  We demonstrated 
human erythrocyte and leukocyte sensing by platinum black electroplated micro 
electrodes with high signal-to-noise ratio.  The histograms of the signal magnitude 
matched well with previous published volume distributions of the erythrocytes and 
leukocytes.  The advantages of downsizing electrodes and the sensing zone in 
microdevices include increased sensitivity, lowered sample dilution factor, and thus 
increased system throughput. 
The new approach of inductor-induced impedance sensing overcomes the problem 
of the small double-layer in micro impedance sensing for particles in fluidic flow.  Two 
types of devices were designed and fabricated.  One performs sensing at single frequency.  
The other can sense system impedance change at dual frequencies.  Parallel inductors 
were introduced to induce system resonance.  From impedance spectra measurements, a 
single peak was discovered for each inductance value.  The inductor was shown to 
mainly cancel out the stray capacitance at the resonant frequency.  Based on the model 
we developed, the sensitivity to the channel resistance was the highest at the resonant 
frequency and one order of magnitude larger than the system without the parallel inductor.  
The devices were first tested with 5 μm and 10 μm polystyrene beads.  Human 
erythrocyte and leukocyte sensing was then demonstrated with this approach.  For the 
device using single-frequency sensing, the histograms of the signal magnitude matched 
well with previous published volume distributions of the erythrocytes and leukocytes.  
For the device using dual-frequency sensing, the scatter plots clearly distinguish between 
5 μm and 10 μm beads, as well as leukocytes and erythrocytes.  The feasibility of 
detection of circulating tumor cells in blood was demonstrated by dual-frequency 
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resonance impedance sensing with blood samples spiked with cultured tumor cells. The 
advantages of downsizing electrodes and the sensing zone in microdevices include 
increased sensitivity, lowered sample dilution factor, and thus increased system 
throughput.  The sensing frequency can be flexibly selected by changing the inductance. 
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CHAPTER 4 
LEUKOCYTE DIFFERENTIAL FROM 
UNDILUTED WHOLE BLOOD 
 
4.1 Introduction 
Leukocytes (white blood cells, WBCs) respond to toxic, infectious and 
inflammatory processes to defend tissues and eliminate disease process or toxic 
challenges [1].  Accurate and prompt counting and differentiation of leukocytes is critical 
for differentiating between bacterial and viral infectious disease, recognizing malignant 
disease such as leukemia and the presence of and staging of HIV, assessing allergic 
conditions, and monitoring bone marrow function or the body’s response to various 
treatments [2]. 
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4.1.1 Methods of leukocyte differential 
Leukocyte differential currently can be performed either manually or by 
conventional automated blood analyzers.  Manual leukocyte differential analysis began 
over 100 years ago, when Paul Ehrlich stained cell nucleus and cytoplasm granules with 
aniline dyes developed for the textile industry and found that leukocytes show different 
colors [3].  Manual blood analysis requires making a blood smear or the use of 
hemacytometers and then counting by a trained professional.  One of the Romanowsky 
stain (i.e., Giemsa, Jenner, Wright, or Leishman stain) procedures, which are based on 
cell affinity for neutral, basic, or acidic dyes, is normally used in the procedure for a 5-
part differential.  It is time consuming, labor intensive, and error prone. 
Between the manual blood smear count and automated flow-cytometer-based 
conventional blood counters, there were also attempts to use a computer-controlled 
microscope to differentiate leukocytes based on structure and coloration of nucleated 
blood cells which had been fixed and stained in a blood smear [4−9].  They were largely 
unsuccessful in practical diagnostic settings due to their inability to improve precision 
under the requirement of substantial throughput increase, and the inability of algorithmic 
structural identification of leukocyte subtypes to replace the professional morphologist. 
Automated blood counters are usually based on flow cytometry and employ one 
or a combination of electrical impedance sensing, light scattering measurement, and 
chemical or immuno staining followed by optical sensing.  In electrical impedance 
sensing, RBCs are removed by lysing reagent saponin, or some more sophisticated lysing 
reagent including surfactants.  During the lysing process, the leukocyte cell volume 
changes depending on cell type, due to the leakage of cytoplasm contents and cell 
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nucleus shrinkage in varying amounts [10].  Thus normally 2-part (lymphocytes versus 
granulocytes) or even 3-part (lymphocytes, neutrophils, and other leukocytes) leukocyte 
differential can be achieved by simply electrical impedance measurement of particle 
volume [11−15].  Combining DC and AC impedance, special acidic hemolysis in 
basophil channel and alkali hemolysis in eosinophil channel, a 5-part leukocyte 
differential can be achieved [16].  Due to the dynamics of the lysis procedure, dilution, 
mixing, temperature, and time need to be perfectly controlled, so fully automated 
instruments are required for reliable 3-part and 5-part differential.  Later optical methods 
based on light scattering and fluorescence staining of organelles, granules, and nuclei 
becomes an alternative method.  Generally, low-angle scattered light contains 
information on cell size and high-angle scattered light can be used to probe internal 
composition of the cell.  To achieve 5-part differential, eosinophils requires some special 
stain to change its scattering characteristics from other granulocytes, and basophils need 
to be counted separately after differential lysis of other leukocytes [1, 10].  The first flow-
cytometer-based automated optical leukocyte differential instrument, Hemolog-D by 
Technicon, uses three different channels: lymphocytes, neutrophils, and eosinophils 
classified by myeloperoxidase staining; monocytes identified by staining intracellular 
nonspecific esterase; and basophils identified by Alcian blue staining [17].  Later, Coulter 
Electronics, Inc., combined electrical impedance and light scattering and developed their 
VCS technology, which uses DC resistance sensing to measure cell volume; AC 
impedance sensing to collect information on cell size and internal structure (including 
chemical composition and nuclear volume); and light scattering for cellular granularity, 
nuclear lobularity, and cell surface structure [4].  Generally speaking, conventional 
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automated blood analyzers are bulky, expensive, and mechanically complex.  They 
require larger sample volumes and generate more waste than the systems developed using 
microdevices.  They are usually found only in hospitals or central laboratories, and it 
normally takes from hours to even days for a patient to get the results. 
Micro blood counters promise to provide a point-of-care solution.  They cost less 
and can be more accurate than a manual count.  Particle (bead, erythrocyte, and cultured 
cell) counting has been demonstrated, for example, by electrical impedance sensing 
[18−21], light scattering detection [22, 23] and fluorescent sensing [21, 24−27] in 
microsystems.  All of these previous studies use diluted samples.  Here human leukocyte 
counting and differentiation with microfabricated devices from undiluted human blood is 
reported for the first time.  Dilution is normally required as one of the sample preparation 
steps in blood cell counting and differentiation.  There are several reasons for this.  First 
dilution prevents the coincidence effect in which multiple cells appear in the detection 
zone simultaneously.  Because of the ratio of erythrocytes to leukocytes is on the order of 
a thousand to one, for electrical impedance or light scattering detection of leukocytes, a 
blood sample dilution factor from one hundred to several tens of thousand is typically 
required to avoid erythrocyte interference.  Even for counting leukocytes in samples 
where leukocytes are specifically fluorescent labeled, a dilution of at least ten times is 
performed.  Secondly, dilution reduces the risk of sample clogging in the flow chamber.  
This is a major concern for macroscopic blood counters, since the flow chamber is used 
in continuous mode and removing the clog or replacing the flow chamber can be difficult.  
The third reason is that the whole blood is diluted during the chemical hemolysis process 
to remove erythrocytes, especially when electrical impedance or light-scattering detection 
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is employed.  Hemolysis can produce inaccurately high leukocyte counts due to lysis-
resistant erythrocytes, and inaccurately low counts because some leukocytes are lysed.  
Finally in some protocols an additional fixation buffer is required to conserve the 
properties of leukocytes.   
4.1.2 Optical-sensing-based flow cytometers 
Although the first automated differential blood counters commercially available 
were image analyzers that scanned blood smears prepared with either Giemsa’s or 
Wright’s staining, modern automated blood analyzers are mainly based on flow 
cytometers.  One difference between them is that blood counters require volume 
measurement while flow cytometers do not.  Also a lot of the flow cytometers have cell 
sorting capability by electrically and/or mechanically diverting and collecting cells after 
sensing. 
Applications of flow cytometry typically involve using fluorescent probes to stain 
cellular components or functions.  Optical fluorescent sensing was introduced in flow 
cytometry in the late 1960s [28, 29].  Fluorescent sensing in flow cytometry is more 
precise than static or scanning cytometry due to the short and uniform sensing time and 
thus limited photobleaching.  It is also more sensitive than absorption measurements 
because of its dark field nature.  Modern flow cytometers can take “snapshots” of single 
cells with a throughput up to approximately 50,000 cells/second [26, 30].  The measured 
cellular properties can be morphological, biochemical and functional, such as size, shape, 
DNA/RNA content, cell surface markers, cell cycle distribution and viability. 
With the advance of microfabrication, microdevices have been investigated to 
replace glass capillary-based flow chambers, integrate compact optics and provide on-
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chip sample transport.  Glass and silicon [23, 31−34], fused silica or quartz [35, 36], 
PMMA [22, 37], polyimide [18, 38], plastic Mylar [39], and PDMS [25, 26, 36, 40−44] 
have been used as building materials for micro flow cytometers.  Samples are transported 
by syringe pump [18, 22, 23, 31, 33, 35, 37−39, 42, 45], compressed air [25, 43−45], 
vacuum pump [38, 46], or electro-osmotic flow [32].  In most cases liquid 2D or even 3D 
sheath flow is used, but in some cases air sheath flow [41] or no sheath flow [23, 31] are 
demonstrated.  Optical waveguides and solid-state devices have been integrated in micro 
flow cytometers [27, 37, 42].  For leukocyte differential in micro devices based on optical 
sensing, a V-groove microchannel was fabricated by anisotropic wet etching of silicon 
and 3-part leukocyte differential was demonstrated for diluted blood without sheath flow 
by 2-parameter light scattering [23]. 
Currently there are a number of commercially available, general purpose portable 
flow cytometers, including the Beckman Coulter Cell Lab Quanta™ SC 
(http://www.beckmancoulter.com), the Partec CyFlow® SL-3 (http://www.partec.de), and 
the Guava Personal Cell Analysis (PCA) System (http://www.guavatechnologies.com).  
More related to the work described in this chapter are ultracompact or portable flow-
cytometer-based automated hemacytometers commercially available or under 
development.  Beckman Coulter’s COULTER® Ac·T™ Series analyzers 
(http://www.beckmancoulter.com) achieve a 5-part leukocyte differential using electrical 
impedance sensing, light absorbance after cytochemical staining with Sudan Black B [47] 
and Chlorazol Black E [48], and differential acidic lysis (for a basophil differential from 
the rest of the leukocytes).  Drew Scientific Excell 22 (www.drew-scientific.com) uses 
multi-dimensional light scattering and electrical impedance sensing to achieve 5-part 
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leukocyte differential in one minute.  Micronics, Inc., in cooperation with Beckman 
Coulter, Inc., is in development of a portable flow cytometer, which claims to provide 
complete blood count using a droplet of whole blood in less than five minutes 
(www.micronics.net).  The plastic devices are fabricated with thin-film laminate-based 
technology.  Leukocyte differential is performed in one of three channels by multi-angle 
light scattering after RBC lysis.  The other two channels are for hemoglobin and RBC, 
platelet count [39].  Although the above commercial systems are portable, they are still 
bigger, heavier, use more sample/reagents and generate more waste by at least one order 
of magnitude than the technology described in this chapter.  For leukocyte differential, 
these systems require RBC lysis and sample dilution. 
4.1.3 Acridine orange and other fluorescent dyes for leukocyte differential 
To avoid hemolysis, various fluorescent dyes that stain specifically for leukocytes 
have been used for leukocyte differential.  In this way, only leukocytes generate signals 
and normal erythrocytes do not interfere.  Acridine orange was first suggested [49−51] 
and then later become the first fluorescent stain used to aid leukocyte count in blood 
counters in addition to light scattering measurement in the early 1960s [52].  Although it 
was noted that acridine orange could be used to discriminate mononuclear cells from 
granulocytes, the device was never actually built for leukocyte differentials [53].  Later in 
early 1970s, researchers from Bio/Physics Systems demonstrated a 3-part differential 
with acridine orange [54−56], but again it was not commercialized.  About the same time, 
a research group from Block Engineering found a three-dye combination for leukocyte 
differential: basic dye ethidium bromide stains for DNA; the other two acidic 
dyes⎯brilliant sulfaflavine and stilbene disulfonic acid derivative (LN), which have 
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different pKs⎯had different affinity for cell proteins of different pKs [57, 58].  So 
neutrophil granules are stained primarily with LN and eosinophils with sulfaflavine.  
Later it was showed the dye combination could be simplified to ethidium bromide and 
sulfaflavine with scattering measurements.  Later other dyes were suggested for 
leukocyte differential, such as oxazine dyes [59−61], basic orange 21 [62], and a 
polymethine dye [63]. 
Another group of labeling reagents is the fluorescence labeled monoclonal 
antibodies [64−72].  The antibody-based labeling reagents are used to solve the 
problematic counting of monocytes and basophils in manual and automated 
hemacytometers.  Due to the length and the cost of the procedures, they are used mainly 
in reference methods.  For example, a flow cytometric method performing a five-part 
leukocyte differential based on three-color staining with anti-CD45-fluorescein 
isothiocyanate (FITC), anti-CD-14-phycoerythrin (PE)/Cy5, and a cocktail of PElabeled 
anti-CD2, anti-CD16, and anti-HLA-DR antibodies was proposed and evaluated as a 
reference method [70]. 
The approach demonstrated here for leukocyte differential is to stain an undiluted 
whole sample with acridine orange.  Acridine orange (3,6-dimethylaminoacridine) 
belongs to a group of acridine dyes isolated in the late nineteenth century.  It is a pH-
sensitive fluorescent cationic dye.  It is hydrophobic in neutral pH.  It has an absorption 
maximum at 433 nm and fluorescence maximum at 521 nm in ethanol.  If a large excess 
of nucleic acid polymers is added in, its fluorescence emission can increase by up to 
three fold [73, 74].  It binds strongly to double-stranded DNA by electrostatic attraction 
and intercalation of the acridine nucleus between base pairs.  Upon binding, the 
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excitation maximum becomes 502 nm and the emission maximum becomes 525 nm 
(green).  It also binds strongly to RNA and single-stranded DNA, with a shifted 
excitation maximum of 460 nm and an emission maximum of 650 nm (red).  Because it 
is hydrophobic in neutral pH, it can easily diffuse through the cell membrane and cell 
nucleus membrane to bind to RNA and DNA.  In living cells, acridine orange is 
protonated in the acidic environment of lysosomes, which makes it cationic and 
prevents it from leaking out of lysosome membranes.  The aggregated acridine orange 
fluoresces orange so that lysosomes can be labeled [75].  When it is used in leukocyte 
analysis, the cell nucleus is stained green with slightly mixed red because of double 
stranded DNA and single stranded RNA, while the cell cytoplasm is stained red because 
of RNA and lysosomes [51].  Leukocyte count can be achieved by using the strong 
signal from the green fluorescent channel.  Differentiation can be achieved by analyzing 
the signal from the red fluorescence channel since different types of leukocytes have 
different cytoplasm compositions.  Red fluorescence intensity emission of leukocytes is 
lower than that of non-lymphocytes for samples stained over fifteen minutes.  For fresh-
stained leukocytes, a three-part differential (lymphocytes, monocytes, and granulocytes) 
can be achieved by studying the red fluorescent signal of an acridine stained diluted 
blood sample [54, 56].  But the counting has to be performed quickly since monocyte 
fluorescence intensity continues to increase, eventually preventing its differentiation 
from granulocytes.  A five part differential of leukocytes (lymphocytes, monocytes, 
neutrophils, eosinophils, and basophils) has been demonstrated with hypotonic dilution 
and fresh acridine-orange-stained leukocyte samples [55]. 
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Figure 4-1 Acridine orange molecular structure (top) and leukocyte staining results with 
it (bottom). 
 
In the following sections of this chapter, a method for leukocyte differential and 
its implementation in microdevices for leukocyte counting and differentiation without 
sample dilution are described.  Leukocytes stained with acridine orange in an undiluted 
blood sample were counted and differentiated in a micro flow cytometer.  The detection 
zone of the devices is miniaturized so that the average distance between leukocytes is 
longer and the coincidence effect can be minimized.  The device is disposable so that the 
risk of clogging during device life is very low.  Using fluorescent dye acridine orange to 
stain leukocytes specifically means that hemolysis and fixation are not required.  
Examining a blood sample without dilution simplifies sample preparation.  This is 
especially attractive for a lab-on-a-chip system, since sample mixing and buffer storage 
Granulocyte
Lymphocyte
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may complicate the overall system design.  It has been demonstrated that acridine orange 
and anticoagulant can be coated on a device wall [76], so it is possible to apply a blood 
drop directly onto the device without any sample preparation. 
4.2 Device design and fabrication 
The device was fabricated using soft lithography [77].  PDMS and glass were chosen as 
the materials to make the device because of ease of fabrication and the excellent optical 
properties in the wavelengths used in this study.  The channel structure was molded on a 
1 cm by 1 cm PDMS block.  To accommodate the working distance of the optical lens, 
the thickness of the PDMS block was controlled to be less than 3 mm.  The channel depth 
was 16 μm. 
As in Fig. 4-2, hydrodynamic focusing was adopted to control the particle position in 
the detection zone.  In our design, the ratio of cross-sectional area of sheath flow to core 
sample flow was ten to one.  The channel width of the detection zone was 50 μm.  
Considering the parallel flow profile, the width of the focused sample flow should be less 
than 5 μm.  A filter structure upstream of the sample flow zone was designed to filter out 
contaminants, erythrocyte rosettes, and other large particle aggregates to prevent clogging 
in the detection zone. 
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Figure 4-2 Top view of the fabricated device. 
 
4.3 Material and testing setup 
4.3.1 Materials 
PDMS (polydimethylsiloxane) (Sylgard 184) was obtained from Dow Corning, 
Midland, MI.  5 μm green fluorescent polystyrene beads were purchased from Duke 
Scientific Corporations, Fremont, CA.  Cell nucleus stain acridine orange was obtained 
from Molecular Probes, Eugene, OR, and dissolved in water to achieve a 10 mg/mL stock 
solution.  Blood diluent Ficoll-Paque Plus was purchased from Amersham Biosciences, 
Sweden.  10x phosphate buffered saline (PBS) was obtained from Ambion (9625), 
Austin, TX. 
4.3.2 Blood sample preparation and handling 
Fresh human blood was obtained from healthy donors and used within three days.  
EDTA was added to the blood collection tube to prevent coagulation.  For acridine 
orange staining, the stock solution was added to obtain a final dye concentration of 10 
μg/mL.  Staining results were observed under a fluorescent microscope (Nikon E800, 
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Japan) with a triple band filter block DAPI-FITC-TRITC, which has excitation filter 
wavelengths of 385−400 nm, 475−490 nm, and 545−565 nm, and emission filter 
wavelengths of 450−465 nm, 505−535 nm and 580−620 nm.  Images were taken with a 
cooled CCD camera (RT-KE color 3-shot, Diagnostic Instruments, Sterling Heights, MI).  
Rough count of leukocytes was made with a hemacytometer (Hausser Scientific, 
Horsham, PA).  When necessary, blood or fluorescent beads were diluted in Ficoll-Paque 
Plus (specific gravity 1.077 g/mL) to match the specific gravity of the solvent to 
leukocytes.  All fluids were pumped into the devices using syringe pumps (Harvard 
Apparatus Pico Plus, Holliston, MA). 
4.3.3 Optical detection system construction 
The optical system was set up on an optical bench.  It is a transmitted laser 
induced fluorescent (LIF) detection system.  An Ar laser (National Laser NLC210BL, 
488 nm, 15 to 30 mW adjustable, Salt Lake City, UT) was used as the excitation source.  
An aperture of 50 μm diameter was put in front of the laser output to facilitate the 
alignment process and lower the illumination intensity.  An optional laser-line bandpass 
filter (bandwidth equal to 1.9 nm with a central wavelength of 488 nm) was used to 
further purify the laser source.  An optional neutral density filter (NDF) was used to 
attenuate laser excitation.  Alternatively, the pinhole and NDF were replaced by two 
linear glass polarizers (Edmond Optics TECH SPEC, Barrington, NJ) so that the 
illumination level on the device could be easily adjusted.  A long-working-distance 
microscope objective (USMCO M Plan Apo, 10x, 0.28 NA, Dayton, NV) was used as a 
condenser lens.  Another long-working-distance microscope objective (Bausch & Lomb, 
50x, 0.45 NA, Rochester, NY) was used as an objective lens.  Three emission filters were 
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used in our test: 488 nm long pass filter (Chroma HQ500LP, transition width < 4.9 nm, 
edge steepness = 2.5 nm, Rockingham, VT), a green bandpass filter with central 
wavelength 525 nm and bandwidth 50 nm (Chroma D525_50m), and a red bandpass filter 
with central wavelength 650 nm and bandwidth 50 nm (Chroma D650_50m).  A 
broadband non-polarizing hybrid cube beamsplitter (Newport 05BC17MB.1, 400 
nm−700 nm, R/T=45%/45%, Irvine, CA) was used to direct light to the photodiode 
detector and CCD camera simultaneously.  The signal was electrically amplified and 
detected either with a Silicon photodiode receiver module (Electro-Optical Systems, 
UVS-025-H, Phoenixville, PA) or a photon multiplier tube (PMT, Hamamatsu H5784-20, 
Japan).  The voltage signal was sent to a deep memory oscilloscope (HP 54645A, Palo 
Alto, CA).  When the buffer in the oscilloscope was full, the data was loaded to a 
computer and analyzed with a Matlab peak-detection program.  Video was taken with an 
analog CCD camera (Hitachi KP-D20B, Japan) at 30 frames per second and then 
converted to digital format and stored in a computer. 
The detection system was constructed on an optic bench.  Unlike most traditional 
fluorescent detection systems, the constructed laser-induced fluorescent system used a 
transmitted fluorescent configuration instead of a reflective (Epi) configuration.  This 
eliminated the need for dichroic mirrors and made the overall alignment procedure 
straightforward. 
As shown in Fig. 4-3, an Argon laser with 488 nm wavelength was used as the 
excitation source.  The light was limited by either a pin hole and NDF, or alternatively by 
two linear polarizers.  The neutral density filter was normally used in alignment so that 
the center of laser illumination was easily identified.  During experiments, it was 
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normally removed so that maximal illumination could be achieved.  Because of the 
narrow bandwidth of the laser system, the emission filter is optional.  A long-working-
distance 10x microscope objective was used as a condenser lens to focus illumination 
light onto the microdevice detection zone.  Four centimeters distance between the 
condenser lens and the microdevice left enough space for fluidic connections.  The device 
was positioned so that the illumination light went through PDMS first, and then the glass 
substrate.  Transmitted light and fluorescent light then went through a long-working-
distance, high-numerical-aperture objective lens.  An emission filter was used to filter out 
transmitted light 488 nm Ar laser.  Acridine-orange-stained leukocytes display mainly 
green fluorescence centered at 525 nm, but also some orange centered at 650 nm, 
depending on the type of leukocytes.  In our testing, both long pass and various band pass 
filters were used.  The long pass filter passed both emission wavelength bands.  Band 
pass filters selected either the band centered at 525 nm or 650 nm.  A beamsplitter cube 
was used to direct 45% of the light to the CCD camera and 45% to photodiode detector.  
The CCD camera was a good tool for alignment.  The photodiode detector and PMT were 
more sensitive than the CCD camera and had a much faster time response.  During 
testing, the optical system was first roughly aligned on a dummy device with the aid of 
images from CCD camera.  A 10 μm diameter illumination spot on the detection zone 
could be easily achieved with proper alignment. 
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Figure 4-3 Optical system setup 
 
4.3.4 Photobleaching time constant measurement 
The time constant of photobleaching was characterized by filling the device with 
acridine-orange-stained whole blood.  The channel was scanned by the laser spot and the 
entire process was recorded with a CCD camera.  Whenever a fluorescing leukocyte was 
observed with fluorescent emission clearly distinct from the background, we stopped 
moving the laser spot and waited until the leukocyte was photobleached to background 
level.  The images were extracted from the video, converted to 8-bit gray scale images, 
and analyzed with a Matlab program.  The data was fitted to a single time-constant 
exponential decay. 
4.4 Acridine orange staining study 
4.4.1 Optimal staining concentration 
To achieve a high signal-to-noise ratio, it is important to measure the optimal 
acridine orange concentration for leukocyte staining.  1 μg/mL range was used for 
machine counting of leukocytes in ten to twenty-five times diluted blood sample [54].  
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Because of the autofluoresence of acridine orange and its absorption by erythrocytes and 
platelets, higher concentrations of acridine orange increased the background noise.  
Lower concentrations did not provide enough contrast to distinguish leukocytes from 
background.  So there should be an optimal acridine orange concentration to achieve the 
highest signal-to-noise ratio.  To find the optimal concentration of acridine orange for 
leukocyte staining, a series of whole blood samples were stained with acridine orange of 
different concentrations (Fig. 4-4).  Samples were loaded into a hemacytometer and 
observed under a microscope.  10 μg/mL (Fig. 4-4D) gave the highest signal-to-noise 
ratio when viewed using a fluorescent microscope.  Lower concentration yielded 
incomplete staining and longer sensor integration time would be required.  Higher 
concentration increased background fluorescence and thus reduced the signal-to-noise 
ratio. 
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Figure 4-4 Study of the optimal acridine orange concentration of leukocyte staining in 
whole blood.  All the pictures were taken with fluorescent microscope using a 40x 
objective with the same settings for camera except the exposure time for the last one was 
one fifth of the others.  (A) Bright field showing the majority erythrocytes.  (B)-(F): Epi 
fluorescent images with acridine orange concentration of 100 ng/mL, 1 μg/mL, 10 μg/mL, 
100 μg/mL, and 1 mg/mL. 
 
Using a fluorescent microscope, background fluorescence was observed for 
acridine-orange-stained whole blood.  This background fluorescence could come from 
several sources.  First, free or nonspecifically bound acridine orange will fluorescence 
green, although the quantum yield is three times lower [74].  Secondly, erythrocytes are 
reported to be able to absorb acridine orange and reduce the effective stain concentration 
for leukocytes [60].  Thirdly, erythrocytes in whole blood have a basal autofluorescence 
level with Ar laser illumination and 530 nm detection [78].  Aging-related oxidation 
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stress increases this level.  Aged red blood cells produce lipofuscin, which strongly 
fluorescences red under green excitation and usually appears as small intracellular 
structures [79].  Another possible reason is the accumulation of acridine orange in 
platelets, which is related to the low cytosolic pH generated by membrane proton pumps 
[80].  Using a fluorescent microscope with 40x objective, we observed the background 
fluorescence bleached faster than leukocyte fluorescence, and it was accompanied by 
destruction of erythrocytes.  It is reported that erythrocytes are destroyed faster than 
leukocytes because they lack an endomembrane for cell surface repair [81].  Also we 
noticed that aged blood samples had an elevated background level.  These seem to 
support the idea that at least part of the background fluorescence comes from red blood 
cells.  We also observed small particles (1−2 μm) with orange/red fluorescence that 
bleached slower than the background.  It is unclear to us whether they are platelets or 
structures of destructed erythrocytes. 
The distance between the coverslip and grid surface was 100 μm, so under the 
field of view there were stacks of erythrocytes as in Fig. 4-4A, but these erythrocytes did 
not block the fluorescent signal from leukocytes, which suggested that erythrocytes did 
not absorb much in the excitation and emission wavelengths. 
4.4.2 Measurement of photobleaching time constant 
The photobleaching effect for acridine-orange-stained leukocytes inside the 
device was studied.  The illumination was set to be the same as that used in testing.  One 
typical testing result is shown in Fig. 4-5.  The signal was noisy but can be fitted as a 
first-order exponential decay with time constant of 6.4 ± 0.7 second.  Two more tests 
confirmed the time constant was between 1 and 10 seconds. 
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Figure 4-5 Fluorescent signal bleaching from a single leukocyte in the device.  The red 
line is a single exponential fit to the data. 
 
For acridine-orange-stained whole blood, photobleaching was observed for both 
background and leukocytes.  The time constant of leukocyte photobleaching is one 
limitation on the lower bound for the sample flow rate for a given illumination intensity.  
If the photobleaching time constant is much smaller than the time a typical leukocyte 
takes to pass the laser focused spot, it is possible that the fluorescence signal from the 
leukocyte will be bleached even before it reaches the center of the focused spot.  The 
fluorescence change from a single acridine-orange-stained leukocyte inside the channel 
under laser illumination was measured.  The results could be fit by an exponential decay 
with a single time constant.  The time constant fell in the seconds range.  The time for 
one cell to pass the detection zone in our testing was roughly 30 ms for low flow rate and 
1ms for high flow rate.  So photobleaching was not a problem in our experiments.  The 
measured time constant was on the same order of magnitude as that for samples observed 
under the 40x objective of the fluorescent microscope. 
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4.5 System calibration with 5 μm beads 
The overall system was calibrated with 5 μm green fluorescent beads.  The beads 
were diluted with Ficoll-Paque Plus and PBS to a final concentration of about 2×103 /μl.  
Sample flow rate was set to be 3 nL/min and sheath flow was 30 nL/min.  Fig. 4-6 shows 
images from the CCD camera.  With a focused laser beam as in Fig. 4-6A, the beads 
created a enlarged light circle as in Fig. 4-6B.  Only a single bead normally appeared in 
each image.  With diffused laser illumination as in Fig. 4-6C, the trace of the bead could 
be identified (Fig. 4-6D).  To evaluate the effectiveness of the hydrodynamic focusing, 
we analyzed the center positions of all 81 bead events in a period of seven minutes.  The 
beads flowed at the center of the channel with a standard deviation of 0.7 μm (Fig. 4-7).  
Although hydrodynamic focusing adds an additional solution and requires flow control, it 
provides several benefits.  It limits the cross-section area of the detection zone without 
shrinking the channel diameter, thus the signal-to-noise ratio is improved without 
increasing the chance of channel clogging.  Also the reduction of the cross section of the 
core flow reduces the coincidence effect.  Finally, enclosing the core sample flow with 
sheath flow minimizes fluorescent dye absorption in the device walls, thus reducing 
background noise.  Fig. 4-8 shows 5 μm bead signals from the photodiode detector.  The 
detector was set at high sensitivity mode.  Peaks could be easily identified. 
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Figure 4-6 Images of 5 μm beads flow taken by CCD camera with long pass emission 
filter.  (A) and (B) are images of background and a bead with focused laser illumination.  
The laser spot in (A) shows the position of the focused laser spot.  (C) and (D) are images 
of background and a bead with diffused laser illumination.  (D) shows the trace of the 
bead. 
 
Figure 4-7 Histogram of centroids of bead images from CCD camera 
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Figure 4-8 5 μm fluorescent beads detection with photodiode detector with long pass 
emission filter 
 
4.6 Testing with undiluted whole blood 
To prepare the sample, 1 μl 1 mg/mL acridine orange stock solution was added to 
100 μl whole human blood.  10x PBS diluted to 1x with Ficoll Phage Plus was used as a 
sheath flow solution.  When the analog CCD camera was used for video recording, a 3 
nL/min sample flow rate and 30 nL/min sheath flow rate were used to match the camera 
frame rate.  For photodiode detection, a 0.1 μL/min sample flow rate and 1 μL/min sheath 
flow rate were used.  The detector was set for low sensitivity mode to decrease its 
response time.  Up to 1 μL/min sample flow and 10 μL/min sheath flow could be used 
with the PMT detector. 
Fig. 4-9 shows images extracted from video taken by the CCD camera.  The 
signal from an acridine-orange-stained leukocyte was not as strong as that from 5 μm 
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fluorescent beads, but the low flow rate gave the CCD camera enough integration time so 
that the signal generated by a passing cell could be identified. 
 
Figure 4-9 Images extracted from video taken by CCD camera with long pass emission 
filter.  (a) background image showing focused laser beam.  (b) signal from a leukocyte. 
 
For photodiode detection, the expected leukocyte detection rate would be, on 
average, 4−11 cells per second for a normal individual.  Both green and red emission 
filter was used.  Fig.4-10 is a time trace over 50 seconds of an undiluted blood sample 
stained with acridine orange using a green emission filter.  The results from testing on 
two blood samples were summarized in table I.  Manual count by hemacytometer was 
repeated at least five times with 10:1 diluted samples.  The standard deviations only 
include data variation but do not account for dilution which was normally in the 10−15% 
range.  Each device count was calculated for 50 seconds.  Counting was repeated with the 
same sample loading.  Sample one was counted three times and sample two was counted 
eleven times.  With the PMT detector, a throughput of up to about 100 leukocytes per 
second was achieved. 
   
 
 
165
Time (second)
V
ol
ta
ge
 (v
ol
t)
V
ol
ta
ge
 (v
ol
t)
 
Figure 4-10 Time trace of amplified photodiode signal of acridine orange stained 
undiluted whole blood with green emission filter centered at 525 nm.  Peaks are labeled. 
 
For our device count, blood cell sedimentation contributed greatly to the counting 
error.  For whole blood inside a test tube, sedimentation is normally complete in an hour.  
During testing, after we loaded the device with sample, fine alignment of the optical 
system was required.  Normally we finished this process in ten minutes.  Also it took five 
to ten minutes for the syringe pumps and the fluidic system to form steady 
hydrodynamically focused flow.  On the other hand, the diameters of the syringe needle 
and tubing for connection were less than 1 mm, so the sedimentation distance for 
leukocytes was very small.  The counts we got normally varied with time.  The large 
count deviation in sample two was partly because the time duration to take eleven counts 
was about thirty minutes.  For this reason, it is beneficial to increase the flow rate so that 
each count can be completed in a shorter time. 
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Maximal signal intensity was studied by plotting its histogram.  Fig. 4-11 shows 
the results with 525 nm emission filter.  One peak was identified.  According to a 
previous study [56], the lower-intensity portion is contributed mainly by lymphocytes, 
while the higher-intensity portion is from monocytes.  The center region is mostly 
granulocytes.  Fig. 4-12 was the result from the 650 nm emission filter.  Two peaks were 
identified, which agreed well with previous study.  The peak at lower intensity is 
dominated by lymphocytes and the higher-intensity peak is mostly monocytes and 
granulocytes.  The time between start of staining to photodiode recording in our testing 
was normally longer than fifteen minutes, so the samples were not fresh enough to 
demonstrate a separate monocyte peak in the 650 nm histogram [55, 56]. 
 
 
Figure 4-11 Histogram of signal intensity from photodiode detector with green emission 
filter centered at 525 nm 
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Figure 4-12 Histogram of signal intensity from photodiode detector with red emission 
filter centered at 650 nm 
 
In our testing, the maximal throughput was about a hundred leukocytes per second 
with the PMT detector.  Under the maximal throughput, the total time for counting a 
minimum of 200 leukocytes was a couple of seconds, which is adequate for our 
application.  The overall system throughput is limited by several factors.  First, sample 
dilution lowers the throughput by increasing total sample volume.  In our study, undiluted 
blood was used.  In this way minimal sample volume was used for sensing a certain 
target number of leukocytes.  Secondly, sample throughput is proportional to volume 
flow rate, but is limited by the maximal pumping rate and response time of the sensing 
system.  In our testing, a 3 nL/min core flow rate was used with CCD camera detection.  
This is the highest flow rate for optimal signal-to-noise ratio of the analog CCD camera, 
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because, under this flow rate, a typical leukocyte traveled through the detection zone in 
30 milliseconds, which roughly equals the CCD frame acquisition time.  A 100 nL/min 
sample flow rate was used for photodiode detection and 1 μL/min for that of the PMT.  
These were roughly the highest flow rates we could use for the detection without signal 
distortion.  Under these flow rates, a typical leukocyte flowed by the detection zone in 
about 1 ms in photodiode detection and 0.1 ms for PMT detection.  The time response of 
the photodiode receiver module under low sensitivity setting was 0.16 ms and that under 
high sensitivity was 0.6 ms.  The time response of the PMT was 16 μs.  In our system, 
these were the limiting factors for higher throughput.  By using a detection system with 
faster time response, it is possible to increase the flow rates and thus the throughput by 
orders of magnitude.  Thirdly, the cross-section area of the core flow in the detection 
zone is also related to throughput.  Given the same volume flow rate, decreasing this area 
increases the linear flow velocity of the core flow.  This requires a faster sensing system, 
but can reduce coincidence effect by increasing the average distance between cells in the 
detection zone. 
4.7 Conclusion and on-going work 
A microfluidic device was fabricated and a LIF-based flow cytometer system was 
demonstrated for leukocyte counting and differentiation from undiluted whole human 
blood.  Leukocytes were selectively stained with fluorescent dye acridine orange with the 
optimal final concentration of 10 μg/mL.  A Green fluorescent channel centered at 525 
nm was used for leukocyte counting, and a red fluorescent channel centered at 650 nm 
was used for leukocyte differentiation.  Maximal throughput of 100 leukocytes per 
second was achieved.  The photobleaching time constant of acridine orange in the current 
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detection system was measured to be in the seconds range.  Leukocyte counting and 
differential from undiluted blood was enabled by labeling leukocytes specifically and by 
the microfluidic implementation.  Handling blood samples without dilution not only 
greatly reduced sample/waste volume and processing time, but also eliminated on-chip 
mixing and buffer storage completely.  These advantages are especially attractive for 
point-of-care devices. 
After the successful demonstration of the WBC differential on the optical bench, a 
detection system based on a modified fluorescent microscope was built at the 
collaborators’ site (Fig. 4-13).  High-illumination LED was used for excitation and a 
minipump was successfully used to manipulate the sample in suction mode.  Fluorescent 
signals from green and red channels were able to be detected simultaneously with two 
PMTs.  A handheld instrument based on the technology discussed in this chapter is under 
development by Iris International, Inc. (Fig. 4-14). 
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Figure 4-13 (A) System based on modified microscope. (Courtesy Iris International, Inc.) 
(B) Detection by red (top) and green (bottom) fluorescence channel simultaneously. 
 
 
Figure 4-14 A handheld instrument under development. (Courtesy Iris International, Inc.) 
(A) Mockup box showing individual components.  (B) Mechanical design of the detection 
box.  (C) Assembled detection box. 
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CHAPTER 5 
CONCLUSIONS 
 
Blood count is the cornerstone of the modern hematology laboratory.  Since the 
discovery of blood composition in the 1850s, it has become one of the most common 
laboratory tests performed today.  The methods for blood count are driven by technology 
advance.  Manual count was the only method available before the mid-1950s and is still 
in use, especially in developing countries.  It has been replaced gradually during the past 
fifty years by automated blood analyzers, which are faster and more accurate.  I believe 
the next big technological development in blood count will be point-of-care on-chip 
blood counters, which provide reliable and accurate information even more quickly and 
cheaply.  Such devices can find wide applications in the era of personalized healthcare 
and medicine. 
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To demonstrate feasibility and make working prototypes, this thesis aims to 
explore state-of-the-art microfabrication technologies for making centimeter-size chips 
with tens-of-micron-size features that can perform blood counts.  Three separate have 
angles been taken.  First, two types of micro devices for highly efficient erythrocyte and 
leukocyte separation are demonstrated.  Both the pillar-shaped and the channel-shaped 
devices separate particles of different sizes based on hydrodynamic separation.  
Engineering streamline designs inside microdevices are proved to be effective in 
controlling the critical particle size and the separation profile.  The benefits of the 
channel-shaped devices include continuous and passive separation, small footprint, and 
fewer requirements on flow control.  The second effort was made on erythrocyte and 
leukocyte count by electrical impedance sensing.  Sensitivity improvement of the micro 
impedance sensors is enabled by solving the small double-layer capacitance problem 
inherent to this type of device.  Platinum black electroplating on electrodes is effective in 
sensing at low frequency (less than 1MHz).  Inductor-induced resonance sensing includes 
a parallel inductor to nullify system capacitive components at resonance frequency, 
allowing the optimal sensing frequency to be chosen by the inductance value.  The third 
major contribution of this thesis is the demonstration of a fluorescence-sensing method in 
a micro flow cytometer format for leukocyte differentials with undiluted blood samples.  
Acridine orange was chosen as the differential fluorescence dye because of its well-
known property as a nucleic acid stain and its differential effects for leukocytes.  The 
most important feature of the method is that it does not require any sample dilution, 
which differs from conventional automated blood analyzers and makes this approach 
especially appealing for current microdomain implementation.  The reduction of the 
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coincidence effect is made possible because of minimal interference from the unstained 
erythrocytes, and by reducing the dimension of the sensing zone with microfabrication. 
The successful demonstrations of the devices presented in this thesis enable 
further investigation into on-chip blood analysis.  The separation devices can be 
optimized to separate blood cells for a wider size range.  In this way, for example, 
platelets can be separated from the erythrocytes and counted separately.  In this way, 
blood cell aggregation and adhesion to device surfaces might be reduced.  Also the 
separation devices can be integrated with electrical impedance sensors, so that the 
geometric design of the sensing zones can be optimized for particles of different sizes to 
improve sensitivity.  Instead of coplanar electrodes, parallel overlap ones in impedance 
sensors will improve the scattering caused by particles flowing at different heights inside 
the channel.  Another solution is to use hydrodynamic focusing with sheath flow having 
different dielectric properties from the cells.  For leukocyte differential by fluorescence 
sensing, 3-part and even 5-part differentials are possible with acridine orange.  But to 
achieve that, full automation is required for reliable results because the staining process 
itself is time critical and manual sample preparation introduces too many variables.  
Other cytochemical, fluorescent dyes or labeled antibodies can be explored for better 
staining performance.  The throughput can be improved by at least one to two orders of 
magnitude by designing a transimpedance amplifier with wider bandwidth for optical 
detectors.  Overall system integration with sample preparation, volume measurement, and 
fluidic, electrical and optical coupling is another challenge ⎯ a common problem that 
needs to be solved in the whole microfluidics field. 
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Blood delivers oxygen and nutrients to, and transports metabolic intermediates 
and wastes from every individual cell in the human body, making it a treasure for disease 
diagnostics and patient health monitoring.  The current parameters for blood count only 
provide the bulk picture.  The under-represented cells inside the bloodstream ⎯ which 
are not included in blood count now ⎯ might provide much more significant diagnostic 
information and/or better treatment.  For example, circulating tumor cells, hematopoietic 
stem cells, and nucleated erythrocytes are all not detectable by conventional blood 
analyzers either because their extreme low numbers are not statistically significant or 
because there is no reliable, efficient, and cost-effective way to detect them.  Not even 
mentioned is the promising and challenging field of low abundant plasma protein 
detection.  Over 95% of plasma proteins are at concentrations under the detection limits 
of the current best immunoassays and they are believed to have extremely high medical 
values.  The technological development of hematology will greatly benefit human health 
but there is still much to be done.  Micro and nano technologies provide a unique 
opportunity, and on-chip blood count is only the very beginning. 
